Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Infections and Autoimmunity: A Panorama

Identifieur interne : 000241 ( Pmc/Corpus ); précédent : 000240; suivant : 000242

Infections and Autoimmunity: A Panorama

Auteurs : V. Pordeus ; M. Szyper-Kravitz ; R. A. Levy ; N. M. Vaz ; Y. Shoenfeld

Source :

RBID : PMC:7090595

Abstract

For more than 2,000 years, it was thought that malignant spirits caused diseases. By the end of nineteenth century, these beliefs were displaced by more modern concepts of disease, namely, the formulation of the “germ theory,” which asserted that bacteria or other microorganisms caused disease. With the emergence of chronic degenerative and of autoimmune diseases in the last century, the causative role of microorganisms has been intensely debated; however, no clear explanatory models have been achieved. In this review, we examine the current available literature regarding the relationships between infections and 16 autoimmune diseases. We critically analyzed clinical, serological, and molecular associations, and reviewed experimental models of induction of and, alternatively, protection from autoimmune diseases by infection. After reviewing several studies and reports, a clinical and experimental pattern emerges: Chronic and multiple infections with viruses, such as Epstein–Barr virus and cytomegalovirus, and bacteria, such as H. pylori, may, in susceptible individuals, play a role in the evolvement of autoimmune diseases. As the vast majority of infections pertain to our resident microbiota and endogenous retroviruses and healthy carriage of infections is the rule, we propose to focus on understanding the mechanisms of this healthy carrier state and what changes its configurations to infectious syndromes, to the restoration of health, or to the sustaining of illness into a chronic state and/or autoimmune disease. It seems that in the development of this healthy carriage state, the infection or colonization in early stages of ontogenesis with key microorganisms, also called ‘old friends’ (lactobacilli, bifidobacteria among others), are important for the healthy living and for the protection from infectious and autoimmune syndromes.


Url:
DOI: 10.1007/s12016-007-8048-8
PubMed: 18231878
PubMed Central: 7090595

Links to Exploration step

PMC:7090595

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Infections and Autoimmunity: A Panorama</title>
<author>
<name sortKey="Pordeus, V" sort="Pordeus, V" uniqKey="Pordeus V" first="V." last="Pordeus">V. Pordeus</name>
<affiliation>
<nlm:aff id="Aff1">Clinical Research, Pro Cardiaco Hospital Research Center—PROCEP, Rio de Janeiro, Brazil</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.413795.d</institution-id>
<institution-id institution-id-type="ISNI">0000000121072845</institution-id>
<institution>Center for Autoimmune diseases, Department of Medicine B,</institution>
<institution>Sheba Medical Center,</institution>
</institution-wrap>
Tel Hashomer, Israel</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Szyper Kravitz, M" sort="Szyper Kravitz, M" uniqKey="Szyper Kravitz M" first="M." last="Szyper-Kravitz">M. Szyper-Kravitz</name>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.413795.d</institution-id>
<institution-id institution-id-type="ISNI">0000000121072845</institution-id>
<institution>Center for Autoimmune diseases, Department of Medicine B,</institution>
<institution>Sheba Medical Center,</institution>
</institution-wrap>
Tel Hashomer, Israel</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Levy, R A" sort="Levy, R A" uniqKey="Levy R" first="R. A." last="Levy">R. A. Levy</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.412211.5</institution-id>
<institution>Rheumatology Discipline, Faculty of Medicine,</institution>
<institution>Universidade do Estado do Rio de Janeiro,</institution>
</institution-wrap>
Rio de Janeiro, RJ Brazil</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vaz, N M" sort="Vaz, N M" uniqKey="Vaz N" first="N. M." last="Vaz">N. M. Vaz</name>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.8430.f</institution-id>
<institution-id institution-id-type="ISNI">0000000121814888</institution-id>
<institution>Department of Immunology and Biochemistry–ICB,</institution>
<institution>Universidade Federal de Minas Gerais,</institution>
</institution-wrap>
Belo Horizonte, Brazil</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shoenfeld, Y" sort="Shoenfeld, Y" uniqKey="Shoenfeld Y" first="Y." last="Shoenfeld">Y. Shoenfeld</name>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.413795.d</institution-id>
<institution-id institution-id-type="ISNI">0000000121072845</institution-id>
<institution>Center for Autoimmune diseases, Department of Medicine B,</institution>
<institution>Sheba Medical Center,</institution>
</institution-wrap>
Tel Hashomer, Israel</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">18231878</idno>
<idno type="pmc">7090595</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090595</idno>
<idno type="RBID">PMC:7090595</idno>
<idno type="doi">10.1007/s12016-007-8048-8</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">000241</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000241</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Infections and Autoimmunity: A Panorama</title>
<author>
<name sortKey="Pordeus, V" sort="Pordeus, V" uniqKey="Pordeus V" first="V." last="Pordeus">V. Pordeus</name>
<affiliation>
<nlm:aff id="Aff1">Clinical Research, Pro Cardiaco Hospital Research Center—PROCEP, Rio de Janeiro, Brazil</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.413795.d</institution-id>
<institution-id institution-id-type="ISNI">0000000121072845</institution-id>
<institution>Center for Autoimmune diseases, Department of Medicine B,</institution>
<institution>Sheba Medical Center,</institution>
</institution-wrap>
Tel Hashomer, Israel</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Szyper Kravitz, M" sort="Szyper Kravitz, M" uniqKey="Szyper Kravitz M" first="M." last="Szyper-Kravitz">M. Szyper-Kravitz</name>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.413795.d</institution-id>
<institution-id institution-id-type="ISNI">0000000121072845</institution-id>
<institution>Center for Autoimmune diseases, Department of Medicine B,</institution>
<institution>Sheba Medical Center,</institution>
</institution-wrap>
Tel Hashomer, Israel</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Levy, R A" sort="Levy, R A" uniqKey="Levy R" first="R. A." last="Levy">R. A. Levy</name>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.412211.5</institution-id>
<institution>Rheumatology Discipline, Faculty of Medicine,</institution>
<institution>Universidade do Estado do Rio de Janeiro,</institution>
</institution-wrap>
Rio de Janeiro, RJ Brazil</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vaz, N M" sort="Vaz, N M" uniqKey="Vaz N" first="N. M." last="Vaz">N. M. Vaz</name>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.8430.f</institution-id>
<institution-id institution-id-type="ISNI">0000000121814888</institution-id>
<institution>Department of Immunology and Biochemistry–ICB,</institution>
<institution>Universidade Federal de Minas Gerais,</institution>
</institution-wrap>
Belo Horizonte, Brazil</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shoenfeld, Y" sort="Shoenfeld, Y" uniqKey="Shoenfeld Y" first="Y." last="Shoenfeld">Y. Shoenfeld</name>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.413795.d</institution-id>
<institution-id institution-id-type="ISNI">0000000121072845</institution-id>
<institution>Center for Autoimmune diseases, Department of Medicine B,</institution>
<institution>Sheba Medical Center,</institution>
</institution-wrap>
Tel Hashomer, Israel</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinical Reviews in Allergy & Immunology</title>
<idno type="ISSN">1080-0549</idno>
<idno type="eISSN">1559-0267</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>For more than 2,000 years, it was thought that malignant spirits caused diseases. By the end of nineteenth century, these beliefs were displaced by more modern concepts of disease, namely, the formulation of the “germ theory,” which asserted that bacteria or other microorganisms caused disease. With the emergence of chronic degenerative and of autoimmune diseases in the last century, the causative role of microorganisms has been intensely debated; however, no clear explanatory models have been achieved. In this review, we examine the current available literature regarding the relationships between infections and 16 autoimmune diseases. We critically analyzed clinical, serological, and molecular associations, and reviewed experimental models of induction of and, alternatively, protection from autoimmune diseases by infection. After reviewing several studies and reports, a clinical and experimental pattern emerges: Chronic and multiple infections with viruses, such as Epstein–Barr virus and cytomegalovirus, and bacteria, such as
<italic>H. pylori</italic>
, may, in susceptible individuals, play a role in the evolvement of autoimmune diseases. As the vast majority of infections pertain to our resident microbiota and endogenous retroviruses and healthy carriage of infections is the rule, we propose to focus on understanding the mechanisms of this healthy carrier state and what changes its configurations to infectious syndromes, to the restoration of health, or to the sustaining of illness into a chronic state and/or autoimmune disease. It seems that in the development of this healthy carriage state, the infection or colonization in early stages of ontogenesis with key microorganisms, also called ‘old friends’ (lactobacilli, bifidobacteria among others), are important for the healthy living and for the protection from infectious and autoimmune syndromes.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Nutton, V" uniqKey="Nutton V">V Nutton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="De Flora, S" uniqKey="De Flora S">S De Flora</name>
</author>
<author>
<name sortKey="Quaglia, A" uniqKey="Quaglia A">A Quaglia</name>
</author>
<author>
<name sortKey="Bennicelli, C" uniqKey="Bennicelli C">C Bennicelli</name>
</author>
<author>
<name sortKey="Vercelli, M" uniqKey="Vercelli M">M Vercelli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name>
</author>
<author>
<name sortKey="Rose, Nr" uniqKey="Rose N">NR Rose</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ramos Casals, M" uniqKey="Ramos Casals M">M Ramos-Casals</name>
</author>
<author>
<name sortKey="Jara, Lj" uniqKey="Jara L">LJ Jara</name>
</author>
<author>
<name sortKey="Medina, F" uniqKey="Medina F">F Medina</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yamazaki, M" uniqKey="Yamazaki M">M Yamazaki</name>
</author>
<author>
<name sortKey="Kitamura, R" uniqKey="Kitamura R">R Kitamura</name>
</author>
<author>
<name sortKey="Kusano, S" uniqKey="Kusano S">S Kusano</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Pender, Mp" uniqKey="Pender M">MP Pender</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Severin, Mc" uniqKey="Severin M">MC Severin</name>
</author>
<author>
<name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lundqvist, A" uniqKey="Lundqvist A">A Lundqvist</name>
</author>
<author>
<name sortKey="Isa, A" uniqKey="Isa A">A Isa</name>
</author>
<author>
<name sortKey="Tolfvenstam, T" uniqKey="Tolfvenstam T">T Tolfvenstam</name>
</author>
<author>
<name sortKey="Kvist, G" uniqKey="Kvist G">G Kvist</name>
</author>
<author>
<name sortKey="Broliden, K" uniqKey="Broliden K">K Broliden</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Subair, H" uniqKey="Subair H">H Subair</name>
</author>
<author>
<name sortKey="Tiwana, H" uniqKey="Tiwana H">H Tiwana</name>
</author>
<author>
<name sortKey="Fielder, M" uniqKey="Fielder M">M Fielder</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Newkirk, Mm" uniqKey="Newkirk M">MM Newkirk</name>
</author>
<author>
<name sortKey="Goldbach Mansky, R" uniqKey="Goldbach Mansky R">R Goldbach-Mansky</name>
</author>
<author>
<name sortKey="Senior, Bw" uniqKey="Senior B">BW Senior</name>
</author>
<author>
<name sortKey="Klippel, J" uniqKey="Klippel J">J Klippel</name>
</author>
<author>
<name sortKey="Schumacher, Hr" uniqKey="Schumacher H">HR Schumacher</name>
</author>
<author>
<name sortKey="El Gabalawy, Hs" uniqKey="El Gabalawy H">HS El-Gabalawy</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yoshitomi, H" uniqKey="Yoshitomi H">H Yoshitomi</name>
</author>
<author>
<name sortKey="Sakaguchi, N" uniqKey="Sakaguchi N">N Sakaguchi</name>
</author>
<author>
<name sortKey="Kobayashi, K" uniqKey="Kobayashi K">K Kobayashi</name>
</author>
<author>
<name sortKey="Brown, Gd" uniqKey="Brown G">GD Brown</name>
</author>
<author>
<name sortKey="Tagami, T" uniqKey="Tagami T">T Tagami</name>
</author>
<author>
<name sortKey="Sakihama, T" uniqKey="Sakihama T">T Sakihama</name>
</author>
<author>
<name sortKey="Hirota, K" uniqKey="Hirota K">K Hirota</name>
</author>
<author>
<name sortKey="Tanaka, S" uniqKey="Tanaka S">S Tanaka</name>
</author>
<author>
<name sortKey="Nomura, T" uniqKey="Nomura T">T Nomura</name>
</author>
<author>
<name sortKey="Miki, I" uniqKey="Miki I">I Miki</name>
</author>
<author>
<name sortKey="Gordon, S" uniqKey="Gordon S">S Gordon</name>
</author>
<author>
<name sortKey="Akira, S" uniqKey="Akira S">S Akira</name>
</author>
<author>
<name sortKey="Nakamura, T" uniqKey="Nakamura T">T Nakamura</name>
</author>
<author>
<name sortKey="Sakaguchi, S" uniqKey="Sakaguchi S">S Sakaguchi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kai, H" uniqKey="Kai H">H Kai</name>
</author>
<author>
<name sortKey="Shibuya, K" uniqKey="Shibuya K">K Shibuya</name>
</author>
<author>
<name sortKey="Wang, Y" uniqKey="Wang Y">Y Wang</name>
</author>
<author>
<name sortKey="Kameta, H" uniqKey="Kameta H">H Kameta</name>
</author>
<author>
<name sortKey="Kameyama, T" uniqKey="Kameyama T">T Kameyama</name>
</author>
<author>
<name sortKey="Tahara Hanaoka, S" uniqKey="Tahara Hanaoka S">S Tahara-Hanaoka</name>
</author>
<author>
<name sortKey="Miyamoto, A" uniqKey="Miyamoto A">A Miyamoto</name>
</author>
<author>
<name sortKey="Honda, S" uniqKey="Honda S">S Honda</name>
</author>
<author>
<name sortKey="Matsumoto, I" uniqKey="Matsumoto I">I Matsumoto</name>
</author>
<author>
<name sortKey="Koyama, A" uniqKey="Koyama A">A Koyama</name>
</author>
<author>
<name sortKey="Sumida, T" uniqKey="Sumida T">T Sumida</name>
</author>
<author>
<name sortKey="Shibuya, A" uniqKey="Shibuya A">A Shibuya</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Quinones, Mp" uniqKey="Quinones M">MP Quinones</name>
</author>
<author>
<name sortKey="Jimenez, F" uniqKey="Jimenez F">F Jimenez</name>
</author>
<author>
<name sortKey="Martinez, H" uniqKey="Martinez H">H Martinez</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yamanishi, S" uniqKey="Yamanishi S">S Yamanishi</name>
</author>
<author>
<name sortKey="Iizumi, T" uniqKey="Iizumi T">T Iizumi</name>
</author>
<author>
<name sortKey="Watanabe, E" uniqKey="Watanabe E">E Watanabe</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rocha, F" uniqKey="Rocha F">F Rocha</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kato, I" uniqKey="Kato I">I Kato</name>
</author>
<author>
<name sortKey="Endo Tanaka, K" uniqKey="Endo Tanaka K">K Endo-Tanaka</name>
</author>
<author>
<name sortKey="Yokokura, T" uniqKey="Yokokura T">T Yokokura</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Costalonga, M" uniqKey="Costalonga M">M Costalonga</name>
</author>
<author>
<name sortKey="Hodges, Js" uniqKey="Hodges J">JS Hodges</name>
</author>
<author>
<name sortKey="Herzberg, Mc" uniqKey="Herzberg M">MC Herzberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Schattner, A" uniqKey="Schattner A">A Schattner</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tishler, M" uniqKey="Tishler M">M Tishler</name>
</author>
<author>
<name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tinazzi, E" uniqKey="Tinazzi E">E Tinazzi</name>
</author>
<author>
<name sortKey="Ficarra, V" uniqKey="Ficarra V">V Ficarra</name>
</author>
<author>
<name sortKey="Simeoni, S" uniqKey="Simeoni S">S Simeoni</name>
</author>
<author>
<name sortKey="Artibani, W" uniqKey="Artibani W">W Artibani</name>
</author>
<author>
<name sortKey="Lunardi, C" uniqKey="Lunardi C">C Lunardi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vasudev, M" uniqKey="Vasudev M">M Vasudev</name>
</author>
<author>
<name sortKey="Zacharisen, Mc" uniqKey="Zacharisen M">MC Zacharisen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name>
</author>
<author>
<name sortKey="Aron Maor, A" uniqKey="Aron Maor A">A Aron-Maor</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Delorenze, Gn" uniqKey="Delorenze G">GN DeLorenze</name>
</author>
<author>
<name sortKey="Munger, Kl" uniqKey="Munger K">KL Munger</name>
</author>
<author>
<name sortKey="Lennette, Et" uniqKey="Lennette E">ET Lennette</name>
</author>
<author>
<name sortKey="Orentreich, N" uniqKey="Orentreich N">N Orentreich</name>
</author>
<author>
<name sortKey="Vogelman, Jh" uniqKey="Vogelman J">JH Vogelman</name>
</author>
<author>
<name sortKey="Ascherio, A" uniqKey="Ascherio A">A Ascherio</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Levin, Li" uniqKey="Levin L">LI Levin</name>
</author>
<author>
<name sortKey="Munger, Kl" uniqKey="Munger K">KL Munger</name>
</author>
<author>
<name sortKey="Rubertone, Mv" uniqKey="Rubertone M">MV Rubertone</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Haahr, S" uniqKey="Haahr S">S Haahr</name>
</author>
<author>
<name sortKey="Hollsberg, P" uniqKey="Hollsberg P">P Hollsberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bagos, Pg" uniqKey="Bagos P">PG Bagos</name>
</author>
<author>
<name sortKey="Nikolopoulos, G" uniqKey="Nikolopoulos G">G Nikolopoulos</name>
</author>
<author>
<name sortKey="Ioannidis, A" uniqKey="Ioannidis A">A Ioannidis</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kissler, H" uniqKey="Kissler H">H Kissler</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rubio, N" uniqKey="Rubio N">N Rubio</name>
</author>
<author>
<name sortKey="Sanz Rodriguez, F" uniqKey="Sanz Rodriguez F">F Sanz-Rodriguez</name>
</author>
<author>
<name sortKey="Lipton, Hl" uniqKey="Lipton H">HL Lipton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Croxford, Jl" uniqKey="Croxford J">JL Croxford</name>
</author>
<author>
<name sortKey="Olson, Jk" uniqKey="Olson J">JK Olson</name>
</author>
<author>
<name sortKey="Anger, Ha" uniqKey="Anger H">HA Anger</name>
</author>
<author>
<name sortKey="Miller, Sd" uniqKey="Miller S">SD Miller</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Merkler, D" uniqKey="Merkler D">D Merkler</name>
</author>
<author>
<name sortKey="Horvath, E" uniqKey="Horvath E">E Horvath</name>
</author>
<author>
<name sortKey="Bruck, W" uniqKey="Bruck W">W Bruck</name>
</author>
<author>
<name sortKey="Zinkernagel, Rm" uniqKey="Zinkernagel R">RM Zinkernagel</name>
</author>
<author>
<name sortKey="Del La Torre, Jc" uniqKey="Del La Torre J">JC Del la Torre</name>
</author>
<author>
<name sortKey="Pinschewer, Dd" uniqKey="Pinschewer D">DD Pinschewer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Oldstone, Mb" uniqKey="Oldstone M">MB Oldstone</name>
</author>
<author>
<name sortKey="Von Herrath, M" uniqKey="Von Herrath M">M von Herrath</name>
</author>
<author>
<name sortKey="Evans, Cf" uniqKey="Evans C">CF Evans</name>
</author>
<author>
<name sortKey="Horwitz, Ms" uniqKey="Horwitz M">MS Horwitz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Westall, Fc" uniqKey="Westall F">FC Westall</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mohindru, M" uniqKey="Mohindru M">M Mohindru</name>
</author>
<author>
<name sortKey="Kang, B" uniqKey="Kang B">B Kang</name>
</author>
<author>
<name sortKey="Kim, Bs" uniqKey="Kim B">BS Kim</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mccoy, L" uniqKey="Mccoy L">L McCoy</name>
</author>
<author>
<name sortKey="Tsunoda, I" uniqKey="Tsunoda I">I Tsunoda</name>
</author>
<author>
<name sortKey="Fujinami, Rs" uniqKey="Fujinami R">RS Fujinami</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jun, S" uniqKey="Jun S">S Jun</name>
</author>
<author>
<name sortKey="Gilmore, W" uniqKey="Gilmore W">W Gilmore</name>
</author>
<author>
<name sortKey="Callis, G" uniqKey="Callis G">G Callis</name>
</author>
<author>
<name sortKey="Rynda, A" uniqKey="Rynda A">A Rynda</name>
</author>
<author>
<name sortKey="Haddad, A" uniqKey="Haddad A">A Haddad</name>
</author>
<author>
<name sortKey="Pascual, Dw" uniqKey="Pascual D">DW Pascual</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sewell, Dl" uniqKey="Sewell D">DL Sewell</name>
</author>
<author>
<name sortKey="Reinke, Ek" uniqKey="Reinke E">EK Reinke</name>
</author>
<author>
<name sortKey="Co, Do" uniqKey="Co D">DO Co</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Green, J" uniqKey="Green J">J Green</name>
</author>
<author>
<name sortKey="Casabonne, D" uniqKey="Casabonne D">D Casabonne</name>
</author>
<author>
<name sortKey="Newton, R" uniqKey="Newton R">R Newton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Filippi, C" uniqKey="Filippi C">C Filippi</name>
</author>
<author>
<name sortKey="Von Herrath, M" uniqKey="Von Herrath M">M von Herrath</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jun, Hs" uniqKey="Jun H">HS Jun</name>
</author>
<author>
<name sortKey="Yoon, Jw" uniqKey="Yoon J">JW Yoon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Altobelli, E" uniqKey="Altobelli E">E Altobelli</name>
</author>
<author>
<name sortKey="Petrocelli, R" uniqKey="Petrocelli R">R Petrocelli</name>
</author>
<author>
<name sortKey="Verrotti, A" uniqKey="Verrotti A">A Verrotti</name>
</author>
<author>
<name sortKey="Valenti, M" uniqKey="Valenti M">M Valenti</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="King, C" uniqKey="King C">C King</name>
</author>
<author>
<name sortKey="Ilic, A" uniqKey="Ilic A">A Ilic</name>
</author>
<author>
<name sortKey="Koelsch, K" uniqKey="Koelsch K">K Koelsch</name>
</author>
<author>
<name sortKey="Sarvetnick, N" uniqKey="Sarvetnick N">N Sarvetnick</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gronski, Ma" uniqKey="Gronski M">MA Gronski</name>
</author>
<author>
<name sortKey="Boulter, Jm" uniqKey="Boulter J">JM Boulter</name>
</author>
<author>
<name sortKey="Moskophidis, D" uniqKey="Moskophidis D">D Moskophidis</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Serreze, Dv" uniqKey="Serreze D">DV Serreze</name>
</author>
<author>
<name sortKey="Wasserfall, C" uniqKey="Wasserfall C">C Wasserfall</name>
</author>
<author>
<name sortKey="Ottendorfer, Ew" uniqKey="Ottendorfer E">EW Ottendorfer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Alyanakian, Ma" uniqKey="Alyanakian M">MA Alyanakian</name>
</author>
<author>
<name sortKey="Grela, F" uniqKey="Grela F">F Grela</name>
</author>
<author>
<name sortKey="Aumeunier, A" uniqKey="Aumeunier A">A Aumeunier</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Raine, T" uniqKey="Raine T">T Raine</name>
</author>
<author>
<name sortKey="Zaccone, P" uniqKey="Zaccone P">P Zaccone</name>
</author>
<author>
<name sortKey="Mastroeni, P" uniqKey="Mastroeni P">P Mastroeni</name>
</author>
<author>
<name sortKey="Cooke, A" uniqKey="Cooke A">A Cooke</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saunders, Ka" uniqKey="Saunders K">KA Saunders</name>
</author>
<author>
<name sortKey="Raine, T" uniqKey="Raine T">T Raine</name>
</author>
<author>
<name sortKey="Cooke, A" uniqKey="Cooke A">A Cooke</name>
</author>
<author>
<name sortKey="Lawrence, Ce" uniqKey="Lawrence C">CE Lawrence</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Harley, Jb" uniqKey="Harley J">JB Harley</name>
</author>
<author>
<name sortKey="James, Ja" uniqKey="James J">JA James</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Harley, Jb" uniqKey="Harley J">JB Harley</name>
</author>
<author>
<name sortKey="Harley, It" uniqKey="Harley I">IT Harley</name>
</author>
<author>
<name sortKey="Guthridge, Jm" uniqKey="Guthridge J">JM Guthridge</name>
</author>
<author>
<name sortKey="James, Ja" uniqKey="James J">JA James</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="James, Ja" uniqKey="James J">JA James</name>
</author>
<author>
<name sortKey="Neas, Br" uniqKey="Neas B">BR Neas</name>
</author>
<author>
<name sortKey="Moser, Kl" uniqKey="Moser K">KL Moser</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Parks, Cg" uniqKey="Parks C">CG Parks</name>
</author>
<author>
<name sortKey="Cooper, Gs" uniqKey="Cooper G">GS Cooper</name>
</author>
<author>
<name sortKey="Hudson, Ll" uniqKey="Hudson L">LL Hudson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, Cj" uniqKey="Chen C">CJ Chen</name>
</author>
<author>
<name sortKey="Lin, Kh" uniqKey="Lin K">KH Lin</name>
</author>
<author>
<name sortKey="Lin, Sc" uniqKey="Lin S">SC Lin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mockridge, Ci" uniqKey="Mockridge C">CI Mockridge</name>
</author>
<author>
<name sortKey="Rahman, A" uniqKey="Rahman A">A Rahman</name>
</author>
<author>
<name sortKey="Buchan, S" uniqKey="Buchan S">S Buchan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bengtsson, A" uniqKey="Bengtsson A">A Bengtsson</name>
</author>
<author>
<name sortKey="Widell, A" uniqKey="Widell A">A Widell</name>
</author>
<author>
<name sortKey="Elmstahl, S" uniqKey="Elmstahl S">S Elmstahl</name>
</author>
<author>
<name sortKey="Sturfelt, G" uniqKey="Sturfelt G">G Sturfelt</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hemauer, A" uniqKey="Hemauer A">A Hemauer</name>
</author>
<author>
<name sortKey="Beckenlehner, K" uniqKey="Beckenlehner K">K Beckenlehner</name>
</author>
<author>
<name sortKey="Wolf, H" uniqKey="Wolf H">H Wolf</name>
</author>
<author>
<name sortKey="Lang, B" uniqKey="Lang B">B Lang</name>
</author>
<author>
<name sortKey="Modrow, S" uniqKey="Modrow S">S Modrow</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Seishima, M" uniqKey="Seishima M">M Seishima</name>
</author>
<author>
<name sortKey="Oyama, Z" uniqKey="Oyama Z">Z Oyama</name>
</author>
<author>
<name sortKey="Yamamura, M" uniqKey="Yamamura M">M Yamamura</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hrycek, A" uniqKey="Hrycek A">A Hrycek</name>
</author>
<author>
<name sortKey="Kusmierz, D" uniqKey="Kusmierz D">D Kusmierz</name>
</author>
<author>
<name sortKey="Mazurek, U" uniqKey="Mazurek U">U Mazurek</name>
</author>
<author>
<name sortKey="Wilczok, T" uniqKey="Wilczok T">T Wilczok</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, H" uniqKey="Wang H">H Wang</name>
</author>
<author>
<name sortKey="Nicholas, Mw" uniqKey="Nicholas M">MW Nicholas</name>
</author>
<author>
<name sortKey="Conway, Kl" uniqKey="Conway K">KL Conway</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chang, M" uniqKey="Chang M">M Chang</name>
</author>
<author>
<name sortKey="Pan, Mr" uniqKey="Pan M">MR Pan</name>
</author>
<author>
<name sortKey="Chen, Dy" uniqKey="Chen D">DY Chen</name>
</author>
<author>
<name sortKey="Lan, Jl" uniqKey="Lan J">JL Lan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mittleman, Bb" uniqKey="Mittleman B">BB Mittleman</name>
</author>
<author>
<name sortKey="Morse, Hc" uniqKey="Morse H">HC Morse</name>
</author>
<author>
<name sortKey="Payne, Sm" uniqKey="Payne S">SM Payne</name>
</author>
<author>
<name sortKey="Shearer, Gm" uniqKey="Shearer G">GM Shearer</name>
</author>
<author>
<name sortKey="Mozes, E" uniqKey="Mozes E">E Mozes</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kuroda, Y" uniqKey="Kuroda Y">Y Kuroda</name>
</author>
<author>
<name sortKey="Nacionales, Dc" uniqKey="Nacionales D">DC Nacionales</name>
</author>
<author>
<name sortKey="Akaogi, J" uniqKey="Akaogi J">J Akaogi</name>
</author>
<author>
<name sortKey="Reeves, Wh" uniqKey="Reeves W">WH Reeves</name>
</author>
<author>
<name sortKey="Satoh, M" uniqKey="Satoh M">M Satoh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Satoh, M" uniqKey="Satoh M">M Satoh</name>
</author>
<author>
<name sortKey="Hamilton, Kj" uniqKey="Hamilton K">KJ Hamilton</name>
</author>
<author>
<name sortKey="Ajmani, Ak" uniqKey="Ajmani A">AK Ajmani</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saikku, P" uniqKey="Saikku P">P Saikku</name>
</author>
<author>
<name sortKey="Leinonen, M" uniqKey="Leinonen M">M Leinonen</name>
</author>
<author>
<name sortKey="Mattila, K" uniqKey="Mattila K">K Mattila</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Danesh, J" uniqKey="Danesh J">J Danesh</name>
</author>
<author>
<name sortKey="Whincup, P" uniqKey="Whincup P">P Whincup</name>
</author>
<author>
<name sortKey="Walker, M" uniqKey="Walker M">M Walker</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Degre, M" uniqKey="Degre M">M Degre</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Beck, Jd" uniqKey="Beck J">JD Beck</name>
</author>
<author>
<name sortKey="Eke, P" uniqKey="Eke P">P Eke</name>
</author>
<author>
<name sortKey="Lin, D" uniqKey="Lin D">D Lin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Frosteg Rd, J" uniqKey="Frosteg Rd J">J Frostegård</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lunardi, C" uniqKey="Lunardi C">C Lunardi</name>
</author>
<author>
<name sortKey="Bason, C" uniqKey="Bason C">C Bason</name>
</author>
<author>
<name sortKey="Corrocher, R" uniqKey="Corrocher R">R Corrocher</name>
</author>
<author>
<name sortKey="Puccetti, A" uniqKey="Puccetti A">A Puccetti</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vliegen, I" uniqKey="Vliegen I">I Vliegen</name>
</author>
<author>
<name sortKey="Herngreen, Sb" uniqKey="Herngreen S">SB Herngreen</name>
</author>
<author>
<name sortKey="Grauls, Ge" uniqKey="Grauls G">GE Grauls</name>
</author>
<author>
<name sortKey="Bruggeman, Ca" uniqKey="Bruggeman C">CA Bruggeman</name>
</author>
<author>
<name sortKey="Stassen, Fr" uniqKey="Stassen F">FR Stassen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lalla, E" uniqKey="Lalla E">E Lalla</name>
</author>
<author>
<name sortKey="Lamster, Ib" uniqKey="Lamster I">IB Lamster</name>
</author>
<author>
<name sortKey="Hofmann, Ma" uniqKey="Hofmann M">MA Hofmann</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Caligiuri, G" uniqKey="Caligiuri G">G Caligiuri</name>
</author>
<author>
<name sortKey="Rottenberg, M" uniqKey="Rottenberg M">M Rottenberg</name>
</author>
<author>
<name sortKey="Nicoletti, A" uniqKey="Nicoletti A">A Nicoletti</name>
</author>
<author>
<name sortKey="Wigzell, H" uniqKey="Wigzell H">H Wigzell</name>
</author>
<author>
<name sortKey="Hansson, Gk" uniqKey="Hansson G">GK Hansson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Binder, Cj" uniqKey="Binder C">CJ Binder</name>
</author>
<author>
<name sortKey="Horkko, S" uniqKey="Horkko S">S Horkko</name>
</author>
<author>
<name sortKey="Dewan, A" uniqKey="Dewan A">A Dewan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cervera, R" uniqKey="Cervera R">R Cervera</name>
</author>
<author>
<name sortKey="Asherson, Ra" uniqKey="Asherson R">RA Asherson</name>
</author>
<author>
<name sortKey="Acevedo, Ml" uniqKey="Acevedo M">ML Acevedo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Uthman, I" uniqKey="Uthman I">I Uthman</name>
</author>
<author>
<name sortKey="Tabbarah, Z" uniqKey="Tabbarah Z">Z Tabbarah</name>
</author>
<author>
<name sortKey="Gharavi, Ae" uniqKey="Gharavi A">AE Gharavi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Van Hal, S" uniqKey="Van Hal S">S van Hal</name>
</author>
<author>
<name sortKey="Senanayake, S" uniqKey="Senanayake S">S Senanayake</name>
</author>
<author>
<name sortKey="Hardiman, R" uniqKey="Hardiman R">R Hardiman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Faghiri, Z" uniqKey="Faghiri Z">Z Faghiri</name>
</author>
<author>
<name sortKey="Wilson, Wa" uniqKey="Wilson W">WA Wilson</name>
</author>
<author>
<name sortKey="Taheri, F" uniqKey="Taheri F">F Taheri</name>
</author>
<author>
<name sortKey="Barton, En" uniqKey="Barton E">EN Barton</name>
</author>
<author>
<name sortKey="Morgan, Os" uniqKey="Morgan O">OS Morgan</name>
</author>
<author>
<name sortKey="Gharavi, Ae" uniqKey="Gharavi A">AE Gharavi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Blank, M" uniqKey="Blank M">M Blank</name>
</author>
<author>
<name sortKey="Asherson, Ra" uniqKey="Asherson R">RA Asherson</name>
</author>
<author>
<name sortKey="Cervera, R" uniqKey="Cervera R">R Cervera</name>
</author>
<author>
<name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Blank, M" uniqKey="Blank M">M Blank</name>
</author>
<author>
<name sortKey="Krause, I" uniqKey="Krause I">I Krause</name>
</author>
<author>
<name sortKey="Magrini, L" uniqKey="Magrini L">L Magrini</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cervera, R" uniqKey="Cervera R">R Cervera</name>
</author>
<author>
<name sortKey="Gomez Puerta, Ja" uniqKey="Gomez Puerta J">JA Gomez-Puerta</name>
</author>
<author>
<name sortKey="Espinosa, G" uniqKey="Espinosa G">G Espinosa</name>
</author>
<author>
<name sortKey="Cucho, M" uniqKey="Cucho M">M Cucho</name>
</author>
<author>
<name sortKey="Font, J" uniqKey="Font J">J Font</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bucciarelli, S" uniqKey="Bucciarelli S">S Bucciarelli</name>
</author>
<author>
<name sortKey="Espinosa, G" uniqKey="Espinosa G">G Espinosa</name>
</author>
<author>
<name sortKey="Cervera, R" uniqKey="Cervera R">R Cervera</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gharavi, Ee" uniqKey="Gharavi E">EE Gharavi</name>
</author>
<author>
<name sortKey="Chaimovich, H" uniqKey="Chaimovich H">H Chaimovich</name>
</author>
<author>
<name sortKey="Cucurull, E" uniqKey="Cucurull E">E Cucurull</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zampieri, S" uniqKey="Zampieri S">S Zampieri</name>
</author>
<author>
<name sortKey="Ghirardello, A" uniqKey="Ghirardello A">A Ghirardello</name>
</author>
<author>
<name sortKey="Iaccarino, L" uniqKey="Iaccarino L">L Iaccarino</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nishikai, M" uniqKey="Nishikai M">M Nishikai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mamyrova, G" uniqKey="Mamyrova G">G Mamyrova</name>
</author>
<author>
<name sortKey="Rider, Lg" uniqKey="Rider L">LG Rider</name>
</author>
<author>
<name sortKey="Haagenson, L" uniqKey="Haagenson L">L Haagenson</name>
</author>
<author>
<name sortKey="Wong, S" uniqKey="Wong S">S Wong</name>
</author>
<author>
<name sortKey="Brown, Ke" uniqKey="Brown K">KE Brown</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tam, Pe" uniqKey="Tam P">PE Tam</name>
</author>
<author>
<name sortKey="Weber Sanders, Ml" uniqKey="Weber Sanders M">ML Weber-Sanders</name>
</author>
<author>
<name sortKey="Messner, Rp" uniqKey="Messner R">RP Messner</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Morrison, Te" uniqKey="Morrison T">TE Morrison</name>
</author>
<author>
<name sortKey="Whitmore, Ac" uniqKey="Whitmore A">AC Whitmore</name>
</author>
<author>
<name sortKey="Shabman, Rs" uniqKey="Shabman R">RS Shabman</name>
</author>
<author>
<name sortKey="Lidbury, Ba" uniqKey="Lidbury B">BA Lidbury</name>
</author>
<author>
<name sortKey="Mahalingam, S" uniqKey="Mahalingam S">S Mahalingam</name>
</author>
<author>
<name sortKey="Heise, Mt" uniqKey="Heise M">MT Heise</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Andrade, Sg" uniqKey="Andrade S">SG Andrade</name>
</author>
<author>
<name sortKey="Campos, Rf" uniqKey="Campos R">RF Campos</name>
</author>
<author>
<name sortKey="Sobral, Ks" uniqKey="Sobral K">KS Sobral</name>
</author>
<author>
<name sortKey="Magalhaes, Jb" uniqKey="Magalhaes J">JB Magalhaes</name>
</author>
<author>
<name sortKey="Guedes, Rs" uniqKey="Guedes R">RS Guedes</name>
</author>
<author>
<name sortKey="Guerreiro, Ml" uniqKey="Guerreiro M">ML Guerreiro</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ohtsuka, T" uniqKey="Ohtsuka T">T Ohtsuka</name>
</author>
<author>
<name sortKey="Yamazaki, S" uniqKey="Yamazaki S">S Yamazaki</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Namboodiri, Am" uniqKey="Namboodiri A">AM Namboodiri</name>
</author>
<author>
<name sortKey="Rocca, Km" uniqKey="Rocca K">KM Rocca</name>
</author>
<author>
<name sortKey="Kuwana, M" uniqKey="Kuwana M">M Kuwana</name>
</author>
<author>
<name sortKey="Pandey, Jp" uniqKey="Pandey J">JP Pandey</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kalabay, L" uniqKey="Kalabay L">L Kalabay</name>
</author>
<author>
<name sortKey="Fekete, B" uniqKey="Fekete B">B Fekete</name>
</author>
<author>
<name sortKey="Czirjak, L" uniqKey="Czirjak L">L Czirjak</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lunardi, C" uniqKey="Lunardi C">C Lunardi</name>
</author>
<author>
<name sortKey="Bason, C" uniqKey="Bason C">C Bason</name>
</author>
<author>
<name sortKey="Navone, R" uniqKey="Navone R">R Navone</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gavanescu, I" uniqKey="Gavanescu I">I Gavanescu</name>
</author>
<author>
<name sortKey="Pihan, G" uniqKey="Pihan G">G Pihan</name>
</author>
<author>
<name sortKey="Halilovic, E" uniqKey="Halilovic E">E Halilovic</name>
</author>
<author>
<name sortKey="Szomolanyi Tsuda, E" uniqKey="Szomolanyi Tsuda E">E Szomolanyi-Tsuda</name>
</author>
<author>
<name sortKey="Welsh, Rm" uniqKey="Welsh R">RM Welsh</name>
</author>
<author>
<name sortKey="Doxsey, S" uniqKey="Doxsey S">S Doxsey</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rodriguez Pla, A" uniqKey="Rodriguez Pla A">A Rodriguez-Pla</name>
</author>
<author>
<name sortKey="Stone, Jh" uniqKey="Stone J">JH Stone</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Eden, A" uniqKey="Eden A">A Eden</name>
</author>
<author>
<name sortKey="Mahr, A" uniqKey="Mahr A">A Mahr</name>
</author>
<author>
<name sortKey="Servant, A" uniqKey="Servant A">A Servant</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Helweg Larsen, J" uniqKey="Helweg Larsen J">J Helweg-Larsen</name>
</author>
<author>
<name sortKey="Tarp, B" uniqKey="Tarp B">B Tarp</name>
</author>
<author>
<name sortKey="Obel, N" uniqKey="Obel N">N Obel</name>
</author>
<author>
<name sortKey="Baslund, B" uniqKey="Baslund B">B Baslund</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chang, Ly" uniqKey="Chang L">LY Chang</name>
</author>
<author>
<name sortKey="Chiang, Bl" uniqKey="Chiang B">BL Chiang</name>
</author>
<author>
<name sortKey="Kao, Cl" uniqKey="Kao C">CL Kao</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Robinson, Jl" uniqKey="Robinson J">JL Robinson</name>
</author>
<author>
<name sortKey="Spady, Dw" uniqKey="Spady D">DW Spady</name>
</author>
<author>
<name sortKey="Prasad, E" uniqKey="Prasad E">E Prasad</name>
</author>
<author>
<name sortKey="Mccoll, D" uniqKey="Mccoll D">D McColl</name>
</author>
<author>
<name sortKey="Artsob, H" uniqKey="Artsob H">H Artsob</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Steed, Al" uniqKey="Steed A">AL Steed</name>
</author>
<author>
<name sortKey="Barton, Es" uniqKey="Barton E">ES Barton</name>
</author>
<author>
<name sortKey="Tibbetts, Sa" uniqKey="Tibbetts S">SA Tibbetts</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shinohara, H" uniqKey="Shinohara H">H Shinohara</name>
</author>
<author>
<name sortKey="Nagi Miura, N" uniqKey="Nagi Miura N">N Nagi-Miura</name>
</author>
<author>
<name sortKey="Ishibashi, K" uniqKey="Ishibashi K">K Ishibashi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Malipiero, U" uniqKey="Malipiero U">U Malipiero</name>
</author>
<author>
<name sortKey="Koedel, U" uniqKey="Koedel U">U Koedel</name>
</author>
<author>
<name sortKey="Pfister, Hw" uniqKey="Pfister H">HW Pfister</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Huugen, D" uniqKey="Huugen D">D Huugen</name>
</author>
<author>
<name sortKey="Xiao, H" uniqKey="Xiao H">H Xiao</name>
</author>
<author>
<name sortKey="Van Esch, A" uniqKey="Van Esch A">A van Esch</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gottenberg, Je" uniqKey="Gottenberg J">JE Gottenberg</name>
</author>
<author>
<name sortKey="Pallier, C" uniqKey="Pallier C">C Pallier</name>
</author>
<author>
<name sortKey="Ittah, M" uniqKey="Ittah M">M Ittah</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fleck, M" uniqKey="Fleck M">M Fleck</name>
</author>
<author>
<name sortKey="Kern, Er" uniqKey="Kern E">ER Kern</name>
</author>
<author>
<name sortKey="Zhou, T" uniqKey="Zhou T">T Zhou</name>
</author>
<author>
<name sortKey="Lang, B" uniqKey="Lang B">B Lang</name>
</author>
<author>
<name sortKey="Mountz, Jd" uniqKey="Mountz J">JD Mountz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Watanabe, S" uniqKey="Watanabe S">S Watanabe</name>
</author>
<author>
<name sortKey="Suzuki, K" uniqKey="Suzuki K">K Suzuki</name>
</author>
<author>
<name sortKey="Kawauchi, Y" uniqKey="Kawauchi Y">Y Kawauchi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Corapcioglu, D" uniqKey="Corapcioglu D">D Corapcioglu</name>
</author>
<author>
<name sortKey="Tonyukuk, V" uniqKey="Tonyukuk V">V Tonyukuk</name>
</author>
<author>
<name sortKey="Kiyan, M" uniqKey="Kiyan M">M Kiyan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Maki Ikola, O" uniqKey="Maki Ikola O">O Maki-Ikola</name>
</author>
<author>
<name sortKey="Heesemann, J" uniqKey="Heesemann J">J Heesemann</name>
</author>
<author>
<name sortKey="Toivanen, A" uniqKey="Toivanen A">A Toivanen</name>
</author>
<author>
<name sortKey="Granfors, K" uniqKey="Granfors K">K Granfors</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hansen, Ps" uniqKey="Hansen P">PS Hansen</name>
</author>
<author>
<name sortKey="Wenzel, Be" uniqKey="Wenzel B">BE Wenzel</name>
</author>
<author>
<name sortKey="Brix, Th" uniqKey="Brix T">TH Brix</name>
</author>
<author>
<name sortKey="Hegedus, L" uniqKey="Hegedus L">L Hegedus</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mandac, Jc" uniqKey="Mandac J">JC Mandac</name>
</author>
<author>
<name sortKey="Chaudhry, S" uniqKey="Chaudhry S">S Chaudhry</name>
</author>
<author>
<name sortKey="Sherman, Ke" uniqKey="Sherman K">KE Sherman</name>
</author>
<author>
<name sortKey="Tomer, Y" uniqKey="Tomer Y">Y Tomer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Minelli, R" uniqKey="Minelli R">R Minelli</name>
</author>
<author>
<name sortKey="Coiro, V" uniqKey="Coiro V">V Coiro</name>
</author>
<author>
<name sortKey="Valli, Ma" uniqKey="Valli M">MA Valli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nagayama, Y" uniqKey="Nagayama Y">Y Nagayama</name>
</author>
<author>
<name sortKey="Saitoh, O" uniqKey="Saitoh O">O Saitoh</name>
</author>
<author>
<name sortKey="Mclachlan, Sm" uniqKey="Mclachlan S">SM McLachlan</name>
</author>
<author>
<name sortKey="Rapoport, B" uniqKey="Rapoport B">B Rapoport</name>
</author>
<author>
<name sortKey="Kano, H" uniqKey="Kano H">H Kano</name>
</author>
<author>
<name sortKey="Kumazawa, Y" uniqKey="Kumazawa Y">Y Kumazawa</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saitoh, O" uniqKey="Saitoh O">O Saitoh</name>
</author>
<author>
<name sortKey="Nagayama, Y" uniqKey="Nagayama Y">Y Nagayama</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Harii, N" uniqKey="Harii N">N Harii</name>
</author>
<author>
<name sortKey="Lewis, Cj" uniqKey="Lewis C">CJ Lewis</name>
</author>
<author>
<name sortKey="Vasko, V" uniqKey="Vasko V">V Vasko</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nagayama, Y" uniqKey="Nagayama Y">Y Nagayama</name>
</author>
<author>
<name sortKey="Watanabe, K" uniqKey="Watanabe K">K Watanabe</name>
</author>
<author>
<name sortKey="Niwa, M" uniqKey="Niwa M">M Niwa</name>
</author>
<author>
<name sortKey="Mclachlan, Sm" uniqKey="Mclachlan S">SM McLachlan</name>
</author>
<author>
<name sortKey="Rapoport, B" uniqKey="Rapoport B">B Rapoport</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cunha Neto, E" uniqKey="Cunha Neto E">E Cunha-Neto</name>
</author>
<author>
<name sortKey="Bilate, Am" uniqKey="Bilate A">AM Bilate</name>
</author>
<author>
<name sortKey="Hyland, Kv" uniqKey="Hyland K">KV Hyland</name>
</author>
<author>
<name sortKey="Fonseca, Sg" uniqKey="Fonseca S">SG Fonseca</name>
</author>
<author>
<name sortKey="Kalil, J" uniqKey="Kalil J">J Kalil</name>
</author>
<author>
<name sortKey="Engman, Dm" uniqKey="Engman D">DM Engman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fairweather, D" uniqKey="Fairweather D">D Fairweather</name>
</author>
<author>
<name sortKey="Rose, Nr" uniqKey="Rose N">NR Rose</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kotilainen, P" uniqKey="Kotilainen P">P Kotilainen</name>
</author>
<author>
<name sortKey="Lehtopolku, M" uniqKey="Lehtopolku M">M Lehtopolku</name>
</author>
<author>
<name sortKey="Hakanen, Aj" uniqKey="Hakanen A">AJ Hakanen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fairweather, D" uniqKey="Fairweather D">D Fairweather</name>
</author>
<author>
<name sortKey="Frisancho Kiss, S" uniqKey="Frisancho Kiss S">S Frisancho-Kiss</name>
</author>
<author>
<name sortKey="Yusung, Sa" uniqKey="Yusung S">SA Yusung</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Omura, T" uniqKey="Omura T">T Omura</name>
</author>
<author>
<name sortKey="Yoshiyama, M" uniqKey="Yoshiyama M">M Yoshiyama</name>
</author>
<author>
<name sortKey="Hayashi, T" uniqKey="Hayashi T">T Hayashi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Richer, Mj" uniqKey="Richer M">MJ Richer</name>
</author>
<author>
<name sortKey="Fang, D" uniqKey="Fang D">D Fang</name>
</author>
<author>
<name sortKey="Shanina, I" uniqKey="Shanina I">I Shanina</name>
</author>
<author>
<name sortKey="Horwitz, Ms" uniqKey="Horwitz M">MS Horwitz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Afanasyeva, M" uniqKey="Afanasyeva M">M Afanasyeva</name>
</author>
<author>
<name sortKey="Rose, Nr" uniqKey="Rose N">NR Rose</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Green, C" uniqKey="Green C">C Green</name>
</author>
<author>
<name sortKey="Elliott, L" uniqKey="Elliott L">L Elliott</name>
</author>
<author>
<name sortKey="Beaudoin, C" uniqKey="Beaudoin C">C Beaudoin</name>
</author>
<author>
<name sortKey="Bernstein, Cn" uniqKey="Bernstein C">CN Bernstein</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Oliveira, Ag" uniqKey="Oliveira A">AG Oliveira</name>
</author>
<author>
<name sortKey="Rocha, Ga" uniqKey="Rocha G">GA Rocha</name>
</author>
<author>
<name sortKey="Rocha, Am" uniqKey="Rocha A">AM Rocha</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Pronai, L" uniqKey="Pronai L">L Pronai</name>
</author>
<author>
<name sortKey="Schandl, L" uniqKey="Schandl L">L Schandl</name>
</author>
<author>
<name sortKey="Orosz, Z" uniqKey="Orosz Z">Z Orosz</name>
</author>
<author>
<name sortKey="Magyar, P" uniqKey="Magyar P">P Magyar</name>
</author>
<author>
<name sortKey="Tulassay, Z" uniqKey="Tulassay Z">Z Tulassay</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saebo, A" uniqKey="Saebo A">A Saebo</name>
</author>
<author>
<name sortKey="Vik, E" uniqKey="Vik E">E Vik</name>
</author>
<author>
<name sortKey="Lange, Oj" uniqKey="Lange O">OJ Lange</name>
</author>
<author>
<name sortKey="Matuszkiewicz, L" uniqKey="Matuszkiewicz L">L Matuszkiewicz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Romero, C" uniqKey="Romero C">C Romero</name>
</author>
<author>
<name sortKey="Hamdi, A" uniqKey="Hamdi A">A Hamdi</name>
</author>
<author>
<name sortKey="Valentine, Jf" uniqKey="Valentine J">JF Valentine</name>
</author>
<author>
<name sortKey="Naser, Sa" uniqKey="Naser S">SA Naser</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Polymeros, D" uniqKey="Polymeros D">D Polymeros</name>
</author>
<author>
<name sortKey="Bogdanos, Dp" uniqKey="Bogdanos D">DP Bogdanos</name>
</author>
<author>
<name sortKey="Day, R" uniqKey="Day R">R Day</name>
</author>
<author>
<name sortKey="Arioli, D" uniqKey="Arioli D">D Arioli</name>
</author>
<author>
<name sortKey="Vergani, D" uniqKey="Vergani D">D Vergani</name>
</author>
<author>
<name sortKey="Forbes, A" uniqKey="Forbes A">A Forbes</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Weinstock, Jv" uniqKey="Weinstock J">JV Weinstock</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gionchetti, P" uniqKey="Gionchetti P">P Gionchetti</name>
</author>
<author>
<name sortKey="Rizzello, F" uniqKey="Rizzello F">F Rizzello</name>
</author>
<author>
<name sortKey="Lammers, Km" uniqKey="Lammers K">KM Lammers</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sydora, Bc" uniqKey="Sydora B">BC Sydora</name>
</author>
<author>
<name sortKey="Tavernini, Mm" uniqKey="Tavernini M">MM Tavernini</name>
</author>
<author>
<name sortKey="Doyle, Js" uniqKey="Doyle J">JS Doyle</name>
</author>
<author>
<name sortKey="Fedorak, Rn" uniqKey="Fedorak R">RN Fedorak</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Moreels, Tg" uniqKey="Moreels T">TG Moreels</name>
</author>
<author>
<name sortKey="Nieuwendijk, Rj" uniqKey="Nieuwendijk R">RJ Nieuwendijk</name>
</author>
<author>
<name sortKey="De Man, Jg" uniqKey="De Man J">JG De Man</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hunter, Mm" uniqKey="Hunter M">MM Hunter</name>
</author>
<author>
<name sortKey="Wang, A" uniqKey="Wang A">A Wang</name>
</author>
<author>
<name sortKey="Hirota, Cl" uniqKey="Hirota C">CL Hirota</name>
</author>
<author>
<name sortKey="Mckay, Dm" uniqKey="Mckay D">DM McKay</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Summers, Rw" uniqKey="Summers R">RW Summers</name>
</author>
<author>
<name sortKey="Elliott, De" uniqKey="Elliott D">DE Elliott</name>
</author>
<author>
<name sortKey="Urban, Jf" uniqKey="Urban J">JF Urban</name>
</author>
<author>
<name sortKey="Thompson, Ra" uniqKey="Thompson R">RA Thompson</name>
</author>
<author>
<name sortKey="Weinstock, Jv" uniqKey="Weinstock J">JV Weinstock</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Szyper Kravitz, M" uniqKey="Szyper Kravitz M">M Szyper-Kravitz</name>
</author>
<author>
<name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Suzuki, T" uniqKey="Suzuki T">T Suzuki</name>
</author>
<author>
<name sortKey="Matsushima, M" uniqKey="Matsushima M">M Matsushima</name>
</author>
<author>
<name sortKey="Masui, A" uniqKey="Masui A">A Masui</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stasi, R" uniqKey="Stasi R">R Stasi</name>
</author>
<author>
<name sortKey="Rossi, Z" uniqKey="Rossi Z">Z Rossi</name>
</author>
<author>
<name sortKey="Stipa, E" uniqKey="Stipa E">E Stipa</name>
</author>
<author>
<name sortKey="Amadori, S" uniqKey="Amadori S">S Amadori</name>
</author>
<author>
<name sortKey="Newland, Ac" uniqKey="Newland A">AC Newland</name>
</author>
<author>
<name sortKey="Provan, D" uniqKey="Provan D">D Provan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Musaji, A" uniqKey="Musaji A">A Musaji</name>
</author>
<author>
<name sortKey="Meite, M" uniqKey="Meite M">M Meite</name>
</author>
<author>
<name sortKey="Detalle, L" uniqKey="Detalle L">L Detalle</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, Z" uniqKey="Li Z">Z Li</name>
</author>
<author>
<name sortKey="Nardi, Ma" uniqKey="Nardi M">MA Nardi</name>
</author>
<author>
<name sortKey="Karpatkin, S" uniqKey="Karpatkin S">S Karpatkin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Van Sorge, Nm" uniqKey="Van Sorge N">NM van Sorge</name>
</author>
<author>
<name sortKey="Van Den Berg, Lh" uniqKey="Van Den Berg L">LH van den Berg</name>
</author>
<author>
<name sortKey="Jansen, Md" uniqKey="Jansen M">MD Jansen</name>
</author>
<author>
<name sortKey="Van De Winkel, Jgj" uniqKey="Van De Winkel J">JGJ van de Winkel</name>
</author>
<author>
<name sortKey="Van Der Pol, Wl" uniqKey="Van Der Pol W">WL van der Pol</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tam, Cc" uniqKey="Tam C">CC Tam</name>
</author>
<author>
<name sortKey="Rodrigues, Lc" uniqKey="Rodrigues L">LC Rodrigues</name>
</author>
<author>
<name sortKey="Petersen, I" uniqKey="Petersen I">I Petersen</name>
</author>
<author>
<name sortKey="Islam, A" uniqKey="Islam A">A Islam</name>
</author>
<author>
<name sortKey="Hayward, A" uniqKey="Hayward A">A Hayward</name>
</author>
<author>
<name sortKey="O Brien, Sj" uniqKey="O Brien S">SJ O'Brien</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kountouras, J" uniqKey="Kountouras J">J Kountouras</name>
</author>
<author>
<name sortKey="Deretzi, G" uniqKey="Deretzi G">G Deretzi</name>
</author>
<author>
<name sortKey="Zavos, C" uniqKey="Zavos C">C Zavos</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Watanabe, K" uniqKey="Watanabe K">K Watanabe</name>
</author>
<author>
<name sortKey="Kim, S" uniqKey="Kim S">S Kim</name>
</author>
<author>
<name sortKey="Nishiguchi, M" uniqKey="Nishiguchi M">M Nishiguchi</name>
</author>
<author>
<name sortKey="Suzuki, H" uniqKey="Suzuki H">H Suzuki</name>
</author>
<author>
<name sortKey="Watarai, M" uniqKey="Watarai M">M Watarai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Godschalk, Pc" uniqKey="Godschalk P">PC Godschalk</name>
</author>
<author>
<name sortKey="Heikema, Ap" uniqKey="Heikema A">AP Heikema</name>
</author>
<author>
<name sortKey="Gilbert, M" uniqKey="Gilbert M">M Gilbert</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Geier, Mr" uniqKey="Geier M">MR Geier</name>
</author>
<author>
<name sortKey="Geier, Da" uniqKey="Geier D">DA Geier</name>
</author>
<author>
<name sortKey="Zahalsky, Ac" uniqKey="Zahalsky A">AC Zahalsky</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fae, Kc" uniqKey="Fae K">KC Fae</name>
</author>
<author>
<name sortKey="Oshiro, Se" uniqKey="Oshiro S">SE Oshiro</name>
</author>
<author>
<name sortKey="Toubert, A" uniqKey="Toubert A">A Toubert</name>
</author>
<author>
<name sortKey="Charron, D" uniqKey="Charron D">D Charron</name>
</author>
<author>
<name sortKey="Kalil, J" uniqKey="Kalil J">J Kalil</name>
</author>
<author>
<name sortKey="Guilherme, L" uniqKey="Guilherme L">L Guilherme</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fae, K" uniqKey="Fae K">K Fae</name>
</author>
<author>
<name sortKey="Kalil, J" uniqKey="Kalil J">J Kalil</name>
</author>
<author>
<name sortKey="Toubert, A" uniqKey="Toubert A">A Toubert</name>
</author>
<author>
<name sortKey="Guilherme, L" uniqKey="Guilherme L">L Guilherme</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Guilherme, L" uniqKey="Guilherme L">L Guilherme</name>
</author>
<author>
<name sortKey="Fae, K" uniqKey="Fae K">K Fae</name>
</author>
<author>
<name sortKey="Oshiro, Se" uniqKey="Oshiro S">SE Oshiro</name>
</author>
<author>
<name sortKey="Kalil, J" uniqKey="Kalil J">J Kalil</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Olive, C" uniqKey="Olive C">C Olive</name>
</author>
<author>
<name sortKey="Ho, Mf" uniqKey="Ho M">MF Ho</name>
</author>
<author>
<name sortKey="Dyer, J" uniqKey="Dyer J">J Dyer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Giovannoni, G" uniqKey="Giovannoni G">G Giovannoni</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Perlmutter, Sj" uniqKey="Perlmutter S">SJ Perlmutter</name>
</author>
<author>
<name sortKey="Leitman, Sf" uniqKey="Leitman S">SF Leitman</name>
</author>
<author>
<name sortKey="Garvey, Ma" uniqKey="Garvey M">MA Garvey</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Singer, Hs" uniqKey="Singer H">HS Singer</name>
</author>
<author>
<name sortKey="Loiselle, Cr" uniqKey="Loiselle C">CR Loiselle</name>
</author>
<author>
<name sortKey="Lee, O" uniqKey="Lee O">O Lee</name>
</author>
<author>
<name sortKey="Minzer, K" uniqKey="Minzer K">K Minzer</name>
</author>
<author>
<name sortKey="Swedo, S" uniqKey="Swedo S">S Swedo</name>
</author>
<author>
<name sortKey="Grus, Fh" uniqKey="Grus F">FH Grus</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jablonka, E" uniqKey="Jablonka E">E Jablonka</name>
</author>
<author>
<name sortKey="Lamb, M" uniqKey="Lamb M">M Lamb</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lederberg, J" uniqKey="Lederberg J">J Lederberg</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Rev Allergy Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Rev Allergy Immunol</journal-id>
<journal-title-group>
<journal-title>Clinical Reviews in Allergy & Immunology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1080-0549</issn>
<issn pub-type="epub">1559-0267</issn>
<publisher>
<publisher-name>Humana Press Inc</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">18231878</article-id>
<article-id pub-id-type="pmc">7090595</article-id>
<article-id pub-id-type="publisher-id">8048</article-id>
<article-id pub-id-type="doi">10.1007/s12016-007-8048-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Infections and Autoimmunity: A Panorama</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pordeus</surname>
<given-names>V.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Szyper-Kravitz</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Levy</surname>
<given-names>R. A.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vaz</surname>
<given-names>N. M.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shoenfeld</surname>
<given-names>Y.</given-names>
</name>
<address>
<email>shoenfel@post.tau.ac.il</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1">
<label>1</label>
Clinical Research, Pro Cardiaco Hospital Research Center—PROCEP, Rio de Janeiro, Brazil</aff>
<aff id="Aff2">
<label>2</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.412211.5</institution-id>
<institution>Rheumatology Discipline, Faculty of Medicine,</institution>
<institution>Universidade do Estado do Rio de Janeiro,</institution>
</institution-wrap>
Rio de Janeiro, RJ Brazil</aff>
<aff id="Aff3">
<label>3</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.8430.f</institution-id>
<institution-id institution-id-type="ISNI">0000000121814888</institution-id>
<institution>Department of Immunology and Biochemistry–ICB,</institution>
<institution>Universidade Federal de Minas Gerais,</institution>
</institution-wrap>
Belo Horizonte, Brazil</aff>
<aff id="Aff4">
<label>4</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.413795.d</institution-id>
<institution-id institution-id-type="ISNI">0000000121072845</institution-id>
<institution>Center for Autoimmune diseases, Department of Medicine B,</institution>
<institution>Sheba Medical Center,</institution>
</institution-wrap>
Tel Hashomer, Israel</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>30</day>
<month>1</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2008</year>
</pub-date>
<volume>34</volume>
<issue>3</issue>
<fpage>283</fpage>
<lpage>299</lpage>
<permissions>
<copyright-statement>© Humana Press Inc. 2007</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>For more than 2,000 years, it was thought that malignant spirits caused diseases. By the end of nineteenth century, these beliefs were displaced by more modern concepts of disease, namely, the formulation of the “germ theory,” which asserted that bacteria or other microorganisms caused disease. With the emergence of chronic degenerative and of autoimmune diseases in the last century, the causative role of microorganisms has been intensely debated; however, no clear explanatory models have been achieved. In this review, we examine the current available literature regarding the relationships between infections and 16 autoimmune diseases. We critically analyzed clinical, serological, and molecular associations, and reviewed experimental models of induction of and, alternatively, protection from autoimmune diseases by infection. After reviewing several studies and reports, a clinical and experimental pattern emerges: Chronic and multiple infections with viruses, such as Epstein–Barr virus and cytomegalovirus, and bacteria, such as
<italic>H. pylori</italic>
, may, in susceptible individuals, play a role in the evolvement of autoimmune diseases. As the vast majority of infections pertain to our resident microbiota and endogenous retroviruses and healthy carriage of infections is the rule, we propose to focus on understanding the mechanisms of this healthy carrier state and what changes its configurations to infectious syndromes, to the restoration of health, or to the sustaining of illness into a chronic state and/or autoimmune disease. It seems that in the development of this healthy carriage state, the infection or colonization in early stages of ontogenesis with key microorganisms, also called ‘old friends’ (lactobacilli, bifidobacteria among others), are important for the healthy living and for the protection from infectious and autoimmune syndromes.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Infections</kwd>
<kwd>Autoimmune diseases</kwd>
<kwd>Chronic infection</kwd>
<kwd>Multiple infections</kwd>
<kwd>Old friends</kwd>
<kwd>Healthy carriage</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Humana Press 2008</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p>For more than 2,000 years, physicians believed that all diseases were caused by
<italic>dyscrasia</italic>
, i.e., the imbalance of body humors (blood, phlegm, black, and yellow bile). This medical belief dominated the medical thinking until the nineteenth century [
<xref ref-type="bibr" rid="CR1">1</xref>
] when it was challenged by Rudolf Virchow’s cellular pathology, which stated that diseases derived from perturbations in cellular behavior. Later on, Louis Pasteur’s proposal of the
<italic>germ theory</italic>
and Robert Koch’s postulates lead the medical and scientific communities to accept the infectious origin of diseases. This heralded a new period in medicine and biology: Hundreds of new diseases were described, and new techniques for diagnosis and treatment were developed. In parallel, the phenomena of immunity (capacity to resist infections) started to be systematically studied, hence, giving birth to immunology. With the introduction of basic sanitary systems and antibiotics, infection mortality decreased, and chronic degenerative diseases, namely, atherosclerosis, cancer, and autoimmune diseases, emerged as the leading cause of morbidity and mortality (at least in the Western world) [
<xref ref-type="bibr" rid="CR2">2</xref>
]. These diseases have an inflammatory/immune basis, and the distinction of infectious diseases from inflammatory or autoimmune diseases is not clear-cut.</p>
<p>It is well recognized that viral, bacterial, and parasite infections may be involved in the arousal, flare, and on the other hand, in the prevention of autoimmune diseases [
<xref ref-type="bibr" rid="CR3">3</xref>
]. The purpose of this review is to examine the state-of-the-art research on the relationship between infections and autoimmune diseases. Herein, we examine clinical, serological, and molecular associations between infection and autoimmune diseases. In addition, we review experimental models developed for the induction and protection from autoimmunity by infections.</p>
</sec>
<sec id="Sec2">
<title>Rheumatoid Arthritis</title>
<sec id="Sec3">
<title>Clinical Associations with Infections</title>
<p>The occurrence of rheumatoid arthritis (RA) has been associated with several infections, among them are Epstein–Barr virus (EBV), Parvo B19, and chronic hepatitis C [
<xref ref-type="bibr" rid="CR4">4</xref>
,
<xref ref-type="bibr" rid="CR5">5</xref>
]. In earlier studies, patients with RA exhibited increased titers of anti-EBV nuclear antigen 2 antibodies and increased frequency of circulating EBV-infected B cells compared to the healthy controls [
<xref ref-type="bibr" rid="CR5">5</xref>
]. More recently, they also have been shown to have a tenfold increase in EBV DNA load [
<xref ref-type="bibr" rid="CR6">6</xref>
]. Several similarities exist between RA and Parvo B19 infection: Both states are characterized by a chronic course, morning stiffness, joint deformation and destruction, rheumatoid nodules, as well as by the induction of rheumatoid factor (RF) and of cytokines such as interleukin-6 (IL-6) and transforming growth factor-α (TGF-α). Cases have been reported of RA development after acute Parvo B19 infection and of persistence of B19 RNA and of the VP-1 antigen in the synovial tissue of RA patients [
<xref ref-type="bibr" rid="CR7">7</xref>
]. In a study on bone marrow samples from RA patients, 26% were positive for parvovirus B19, as compared to 4% in an historical control group of bone marrow [
<xref ref-type="bibr" rid="CR8">8</xref>
]. Regarding bacterial infections, RA has been consistently associated with high titers of antibodies against
<italic>Proteus mirabilis</italic>
[
<xref ref-type="bibr" rid="CR9">9</xref>
]. In a prospective study of 246 patients with recently diagnosed inflammatory arthritis, and followed for 1 year, patients’ sera was tested against a panel of microorganisms (
<italic>Proteus mirabilis</italic>
,
<italic>Escherichia coli</italic>
,
<italic>Chlamydia trachomatis</italic>
,
<italic>Salmonella typhi</italic>
,
<italic>Shigella fexneri</italic>
,
<italic>Campylobacer jejune</italic>
,
<italic>Yersinia enterocolitica</italic>
, and
<italic>parvovirus B19</italic>
). Almost half of the patients fulfilled the American College of Rheumatology criteria for RA, 17% fulfilled the European Spondyloarthropathy Study Group (ESSG) criteria for a spondyloarthropathy, and 37% had undifferentiated arthritis. IgM and IgA anti-
<italic>Proteus mirabilis</italic>
antibodies were significantly higher in patients positive for the RF, compared with all other patients groups (
<italic>P</italic>
 < 0.0005 and 0.005). In addition, anti-
<italic>E. coli</italic>
IgM antibodies were also elevated in RF-positive RA patients, suggesting a role for
<italic>P. mirabilis</italic>
and
<italic>E. coli</italic>
infection in early seropositive RA [
<xref ref-type="bibr" rid="CR10">10</xref>
].</p>
</sec>
<sec id="Sec4">
<title>Experimental Models of Induction by Infection</title>
<p>SKG mice spontaneously develop T cell-mediated chronic autoimmune arthritis together with the production of several autoantibodies including RF and extra-articular lesions. These mice fail to develop arthritis in a microbially clean environment. However, a single intraperitoneal injection of zymosan, a crude yeast cell wall extract, can provoke severe arthritis, and β-glucans, which are the main constituents of zymosan, are responsible for the arthritogenic effect. Blockade of the major β-glucan receptor is able to prevent SKG arthritis triggered by β-glucans, and antibiotic treatment of fungi can prevent SKG arthritis in an arthritis-prone microbial environment [
<xref ref-type="bibr" rid="CR11">11</xref>
].</p>
<p>The effect of microbial dose on collagen-induced arthritis (CIA) has been demonstrated regarding
<italic>Mycobacterium tuberculosis</italic>
. CIA can be induced even in CIA-resistant H-2(b) background of C57BL/6 mice when these mice are immunized with CII emulsified in CFA containing a high but not low dose of
<italic>M. tuberculosis</italic>
[
<xref ref-type="bibr" rid="CR12">12</xref>
]. This high dose of
<italic>M. tuberculosis</italic>
seems to be required for maturation of dendritic cells enough to prime CD4+ helper T cells specific to CII antigen in draining lymph nodes of H-2b background of C57BL/6 mice. Using
<italic>Mycobacterium avium</italic>
intradermal injection to induce arthritis, researchers have characterized the importance of the chemokine receptor 2 (CCR2) in the arthritis-prone DBA1/j CCR2-null mouse. This strain has increased susceptibility to autoimmune arthritis induced by immunization with collagen type II (CII) and complete Freund’s adjuvant (CFA). After intradermal infection with
<italic>M. avium</italic>
, a similar arthritis phenotype was detected in CCR2-null mice in the DBA/1j but not in the BALB/c background. These findings demonstrate that the CCR2-null state in an arthritic-prone genetic background leads to increased arthritis susceptibility after infectious (
<italic>M. avium</italic>
) and noninfectious (CII/CFA) challenges [
<xref ref-type="bibr" rid="CR13">13</xref>
]. In an in vitro study on the effects of
<italic>Helicobacter pylori</italic>
antigens on B lymphocytes cultures, autoantibodies, such as IgM RF, anti-single-stranded DNA and anti-phosphatidylcholine antibodies, were detected in the cultures’ supernatant after the stimulation with
<italic>H. pylori</italic>
urease [
<xref ref-type="bibr" rid="CR14">14</xref>
]. Thus, it seems that certain bacteria and fungi can activate arthritogenic T cells and evoke autoimmune arthritis in individuals who are genetically prone to produce arthritogenic autoimmune T cells.</p>
</sec>
<sec id="Sec5">
<title>Experimental Models of Protection by Infection</title>
<p>In a recent study on experimental arthritis, the administration of a helminth extract prevented the development of inflammatory cell infiltration. This extract protected against the cartilage damage in the zymosan–arthritis model [
<xref ref-type="bibr" rid="CR15">15</xref>
]. In another study, the oral administration of the viable bacterium
<italic>Lactobacillus casei</italic>
strain Shirota (LcS) to DBA/1 mice reduced the incidence and the development of CII-induced arthritis and reduced the levels of specific antibodies to CII in serum compared with the control mice [
<xref ref-type="bibr" rid="CR16">16</xref>
]. The administration of LcS also inhibited delayed-type hypersensitivity response to CII in DBA/1 mice immunized with CII and CFA and suppressed the CII-specific secretion of interferon-gamma (INF-γ) from splenocytes ex vivo. These results suggest that the oral administration of LcS is able to modify the humoral and cellular immune responses to CII, and these modifications could result in the reduction of the development of CIA in DBA/1 mice.</p>
<p>Interestingly, the tolerogenic epitope of type II collagen (CII) is structurally mimicked by an epitope within the platelet aggregation-associated protein (PAAP) on
<italic>Streptococcus sanguis</italic>
. Feeding
<italic>S. sanguis</italic>
to DBA/1J pups delayed the onset of arthritis and reduced the rate, final severity, and percentage of affected limbs [
<xref ref-type="bibr" rid="CR17">17</xref>
]. T cells primed with the tolerogenic epitope of CII proliferated more when incubated with PAAP(+)
<italic>S. sanguis</italic>
than with PAAP(−)
<italic>S. gordonii</italic>
or CII, suggesting an antigen-specific transmucosal tolerogenic effect. Therefore, in neonatal mice, bacterial surface antigens that mimic self can transmucosally stimulate antigen-specific inhibitory T cells. In adult mice immunized with CII, these antigen-specific inhibitory T cells manifest later as attenuated arthritis. The PAAP(+)
<italic>S. sanguis</italic>
appear to activate adult memory type II collagen-specific T cells, suggesting that systemic challenge with commensal self-mimicking microorganisms may perpetuate existing autoimmunity.</p>
</sec>
<sec id="Sec6">
<title>Vaccination</title>
<p>The inoculation of live attenuated vaccines has been associated with reactive arthritis and with RA in several reports. In systematic reviews, new onset or relapse of RA, reactive, and chronic arthritis have been associated with the following vaccines: hepatitis B, miniature mass radiography (MMR; predominantly rubella vaccination), tetanus, typhoid/parathyphoid, influenza, polio, varicella, bacillus Calmette–Guerin (BCG), DTP (diphtheria, tetanus, and pertussis), and anthrax [
<xref ref-type="bibr" rid="CR18">18</xref>
<xref ref-type="bibr" rid="CR22">22</xref>
].</p>
<p>Transient arthralgia, acute arthritis, and chronic arthritis have been well recognized since the introduction of the rubella vaccine in the late 1960s. Risk factors associated with these effects were female gender, older age, and possibly some HLA types. However, more recent studies failed to demonstrate an increased risk for chronic arthropathy after rubella vaccination [
<xref ref-type="bibr" rid="CR18">18</xref>
]</p>
</sec>
</sec>
<sec id="Sec7">
<title>Multiple Sclerosis</title>
<sec id="Sec8">
<title>Clinical Associations with Infections</title>
<p>Epidemiological studies have shown a significant higher prevalence of anti-EBV antibodies (100 vs 80–95%) and higher titers of anti-EBV viral capsid and anti-EBV nuclear antigen-1 (EBNA-1) antibodies among MS patients compared to the controls [
<xref ref-type="bibr" rid="CR6">6</xref>
]. In a more recent systematic review of case control studies comparing EBV seropositivity and the risk for MS, an odds ratio of 13.5 was found [
<xref ref-type="bibr" rid="CR6">6</xref>
]. In two recent large-cohorts’ retrospective studies, the strongest predictors of MS were serum levels of IgG antibodies to EBNA complex or EBNA-1 [
<xref ref-type="bibr" rid="CR23">23</xref>
,
<xref ref-type="bibr" rid="CR24">24</xref>
]. Among individuals who later developed MS, serum antibody titers to EBNA complex were similar to those of controls before the age of 20 years, but two- to threefold higher at age 25 years and older. The risk of MS increased according to the antibody titers; the relative risk was 9.4 in persons with high EBNA complex titers as compared to those with low titers. In longitudinal analyses, a fourfold increase in anti-EBNA complex or anti-EBNA-1 titers during the follow-up was associated with a threefold increase in MS risk. These results suggest an age-dependent relationship between EBV infection and development of MS [
<xref ref-type="bibr" rid="CR24">24</xref>
]. Additional works suggest that early-in-life infection with EBV, usually oligo or asymptomatic, has a protective effect as oppose to later-in-life infection, which is associated with an increased risk for the development of MS [
<xref ref-type="bibr" rid="CR25">25</xref>
]. Earlier studies demonstrated that MS patients have defective T-cell control of EBV-infected B cells [
<xref ref-type="bibr" rid="CR6">6</xref>
]. A more recent study showed an increased frequency of CD8+ T cells responding to two immunodominant EBV epitopes. In addition, the authors characterized T cell cross reactivity between EBV antigens and the myelin basic protein [
<xref ref-type="bibr" rid="CR6">6</xref>
]. The higher titers of measles antibodies in MS patients raised the concern of a possible causal association. However, this concern abated after the introduction of the measles vaccine, which was followed by a sharp drop in the incidence of measles not accompanied by a significant change in the incidence of MS [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
<p>In a recent meta-analysis, MS patients were found more likely to exhibit
<italic>Chlamydophila pneumomiae</italic>
(Cpn) DNA in cerebrospinal fluid (CSF); however, no serological association was found both for the sera and the CSF with antibodies against Cpn [
<xref ref-type="bibr" rid="CR26">26</xref>
]. A provocative hypothesis on the association of malaria with the development of MS has been presented. It proposes that comparing the old map of malaria with the later distribution of MS (in USA and Europe) supports the assumption that an early infection with
<italic>Plasmodium</italic>
sp. in childhood prevents later MS disease, whereas a silent infection at the time of adolescence or later might be responsible for the development of MS [
<xref ref-type="bibr" rid="CR27">27</xref>
].</p>
</sec>
<sec id="Sec9">
<title>Experimental Models of Induction by Infection</title>
<p>The classical model for multiple sclerosis inducted by the Theiler’s murine encephalomyelitis virus (TMEV) infection has recently been related to the upregulation of a particular chemokine (CXCL2) during this infection [
<xref ref-type="bibr" rid="CR28">28</xref>
]. Using a transgenic TMEV coding a
<italic>Haemophilus influenza</italic>
peptide, which mimics myelin proteolipid protein (PLP), the authors showed a rapid-onset demyelinating disease in mice. The authors also showed the importance of second signals, such as virus-activated molecules, as the molecular mimicry induced disease only in the TMEV infection context and did not induce disease when PLP was administered with CFA [
<xref ref-type="bibr" rid="CR29">29</xref>
]. In another recent work, researchers have shown that the prior well-resolved infection with lymphocytic choriomeningitis virus (LMCV) during the neonatal period, predisposes adult mice to severe encephalomyelitis caused by a second infection with the same virus, a mechanism proposed as viral “déjà vu” [
<xref ref-type="bibr" rid="CR30">30</xref>
]. In addition, transgenic animal models with the “insertion” of certain viral protein products have also been associated with the induction of multiple sclerosis [
<xref ref-type="bibr" rid="CR31">31</xref>
]. Examining mimics of MS-related encephalitogenic peptides in all known human bacterial and viral peptides, homologies have been found in several organisms, predominantly in nonpathogenic gut bacteria. These suggest that the microorganism responsible for autoimmune activity in MS might be a normally occurring gut bacterium [
<xref ref-type="bibr" rid="CR32">32</xref>
].</p>
</sec>
<sec id="Sec10">
<title>Experimental Models of Protection by Infection</title>
<p>Comparing two mouse strains, one susceptible and the other resistant to encephalitis induced by infection with TMEV, it has been shown that CD4+ T cell numbers and reactivity to the virus capside peptide, were higher in the resistant strain, revealing the role of T CD4 cells in the viral clearance and protection from demyelinating disease [
<xref ref-type="bibr" rid="CR33">33</xref>
]. Viral infection can prime T cells specific for central nervous system (CNS) antigens either through molecular mimicry with CNS proteins or through cytokine responses and bystander activation. In a murine model, mice infected with vaccinia virus encoding myelin protein developed clinical disease only after immune activation either with an unrelated virus such as murine cytomegalovirus or CFA, as opposed to challenge with LMCV, which suppressed autoimmunity [
<xref ref-type="bibr" rid="CR34">34</xref>
]. In another murine model, an oral vaccine against diarrhea bacteria was capable of protecting mice from the establishment of experimental allergic encephalomyelitis (EAE) because of immunization with PLP peptide. The protection from disease was accompanied by increases in IL-4, IL-13, and IL-10 in lymphocytes culture supernatant, whereas a decrease in INF-γ secreting cells was demonstrated in the nonvaccinated mice [
<xref ref-type="bibr" rid="CR35">35</xref>
]. Interestingly, amelioration of EAE has been reported after experimental infection with
<italic>M. bovis</italic>
strain BCG [
<xref ref-type="bibr" rid="CR36">36</xref>
].</p>
</sec>
<sec id="Sec11">
<title>Vaccination</title>
<p>The association of MS and hepatitis B vaccination was first reported in France after the introduction of the recombinant vaccine. MS developed in 35 women who were later found to overrepresent the HLA-DR2 antigen and to have a strong family history of MS. More recently, in three large-scale case control studies, no evidence for HBV vaccination on the development of MS was found [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
</sec>
</sec>
<sec id="Sec12">
<title>Type 1 Diabetes Mellitus</title>
<sec id="Sec13">
<title>Clinical Associations with Infections</title>
<p>Several viruses have been proposed to be associated with type 1 diabetes mellitus (T1DM) such as rubella, coxsackievirus B (Cox B) [
<xref ref-type="bibr" rid="CR37">37</xref>
], rota, mumps, and cytomegalovirus (CMV) [
<xref ref-type="bibr" rid="CR38">38</xref>
]. Patients with congenital rubella syndrome have a high incidence of T1D (12–20%), and 50–80% exhibit anti-islet and anti-insulin antibodies, suggesting a possible role for the rubella virus in T1D. Cross-reactivity has been demonstrated between rubella capsid protein and extracts from human and rat pancreatic islets, and T cells from T1D cross-react with epitopes from rubella viral proteins and the β cell isoform of GAD [
<xref ref-type="bibr" rid="CR39">39</xref>
]. Regarding the role of Cox B, epidemiological studies revealed conflicting results on the frequency of anti-Cox B antibodies in newly diagnosed T1D children as compared to nondiabetic controls [
<xref ref-type="bibr" rid="CR39">39</xref>
] Several authors have isolated Cox B4 and Cox B5 viruses from the pancreas of patients with acute onset T1D, which could induce diabetes in susceptible mice, providing direct evidence for the involvement of Cox B infection in the development of T1D. Sequence homology between P-2C, a noncapsid protein of Cox B4 virus and GAD (which is expressed by beta cells), has been described [
<xref ref-type="bibr" rid="CR39">39</xref>
], and antibodies reacting to P-2C and GAD have been detected in T1D patients, providing a mechanism for Cox B4 involvement in the induction of T1D [
<xref ref-type="bibr" rid="CR39">39</xref>
]. Despite the aforementioned data, other studies reported conflicting results, and no consensus has yet been achieved on the role of these infections on T1D [
<xref ref-type="bibr" rid="CR37">37</xref>
]. Interestingly, children evaluated for multiple infections history (morbilli, parotitis, rubella, pertussis, or varicella) exhibited a higher risk for T1D [
<xref ref-type="bibr" rid="CR40">40</xref>
].</p>
</sec>
<sec id="Sec14">
<title>Experimental Models of Induction by Infection</title>
<p>In animal models, T1D can be induced by viruses either directly through the selective infection of pancreatic cells (rubella and Cox B4 viruses) or indirectly through autoimmune responses against β-cells elicited by viruses such as the Kilham rat virus. This last has been shown to activate macrophages to secrete inflammatory cytokines that up-regulate autoreactive CD8+ T cells and Th1 type CD4+ T cells, thereby, favoring autoimmunity [
<xref ref-type="bibr" rid="CR39">39</xref>
]</p>
<p>Transgenic animal models with the insertion of certain viral protein products have been associated with the induction of T1DM [
<xref ref-type="bibr" rid="CR31">31</xref>
]. In the NOD mice model, lymphocyte proliferation after lymphocyte loss (known as homeostatic proliferation), occurs as oligoclonal expansions, which are highly associated with disease. There is a well-known association of lymphopenia with autoimmune diseases and also with viral infections [
<xref ref-type="bibr" rid="CR41">41</xref>
]. Using a transgenic mouse model of diabetes, which express lymphocytic choriomeningitis virus glycoprotein (LMCV-gp) in pancreatic beta cells and where the animals develop diabetes upon infection with LMCV or gp immunization, the authors characterized the importance of the affinity of TCR and its ligands, as well as the key role of a regulatory molecule, Cbl-b, in induction of T1DM, providing an interesting model to show that the multifactors are involved in overt experimental disease [
<xref ref-type="bibr" rid="CR42">42</xref>
].</p>
</sec>
<sec id="Sec15">
<title>Experimental Models of Protections by Infection</title>
<p>Several viruses, among them the LCMV and the mouse hepatitis virus, have been shown to protect against the development of T1D in susceptible rats (BB) and NOD mice [
<xref ref-type="bibr" rid="CR39">39</xref>
]. A more complex relationship exists between T1DM and Coxsackie B4 (Cox B) infection. On the one hand, Cox B induces disease only if there is a prior level of insulitis. On the other hand, in the absence of this minimum threshold, it protects against diabetes [
<xref ref-type="bibr" rid="CR43">43</xref>
]. Similarly, the encephalomyocarditis virus, which is diabetogenic in some mice strains, prevents T1D in NOD mice [
<xref ref-type="bibr" rid="CR39">39</xref>
]. Prevention of T1D is postulated to involve induction of T-helper 2 immune responses or deletion of effector cells. Another example of protection from T1D by infection come from studies showing that activation of toll-like receptors through microbial elements protects NOD mice from diabetes, corroborating the hygiene hypothesis and suggesting a protective role of infections against autoimmune diseases [
<xref ref-type="bibr" rid="CR44">44</xref>
]. Very recently, it was shown that the experimental infection with
<italic>Salmonella typhimurium</italic>
is able to prevent NOD mice from developing diabetes, even after the induction of the disease with cyclophosphamide [
<xref ref-type="bibr" rid="CR45">45</xref>
]. A similar inhibitory effect was also demonstrated with helminth infection [
<xref ref-type="bibr" rid="CR46">46</xref>
].</p>
</sec>
<sec id="Sec16">
<title>Vaccination</title>
<p>The increasing incidence of T1D around the world raised the concern of a potential role for vaccination as an inciting event. Although one case-control study suggested that early vaccination with
<italic>Hemophylus influenza B</italic>
could be associated with an increased incidence of T1D, a large-scale cohort study that followed 10,000 Finnish children over a 10-year period, found no increased incidence and no vaccination–age association [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
</sec>
</sec>
<sec id="Sec17">
<title>Systemic Lupus Erythematosus</title>
<sec id="Sec18">
<title>Clinical Associations with Infections</title>
<p>Studies suggest that systemic lupus erythematosus (SLE) patients have unusual immune responses to EBV. Analyses of large cohorts of apparently healthy individuals have revealed that the development of SLE is preceded by abnormal antibody responses and the appearance of anti-Sm and anti-60 kD Ro autoantibodies years before clinical disease [
<xref ref-type="bibr" rid="CR47">47</xref>
,
<xref ref-type="bibr" rid="CR48">48</xref>
]. These first lupus-specific autoantibodies arise from particular antibodies directed against EBNA-1. In addition, several recent papers have demonstrated increased viral load, increased numbers of latently infected peripheral B cells, impaired functional T cell responses, and association of the presence of EBV DNA in SLE patients compared with the controls [
<xref ref-type="bibr" rid="CR47">47</xref>
<xref ref-type="bibr" rid="CR49">49</xref>
]. Other authors reproduced similar finding, proposing other associations related to age, gender, anti-EBV immunoglobulin isotype, and CTLA-4 allelic variation [
<xref ref-type="bibr" rid="CR50">50</xref>
]. Furthermore, a positive association has been demonstrated between levels of IgA anti-EBV antibodies and disease activity [
<xref ref-type="bibr" rid="CR51">51</xref>
].</p>
<p>SLE and infectious mononucleosis patients exhibit the same patterns of immunoglobulin gene usage, with common oligoclonal B cells responses. After EBV infection, the expression of these B cell receptors is specifically censored, restoring equilibrium. The continuing high levels in SLE might arise from disordered regulation or chronic reactivation of EBV [
<xref ref-type="bibr" rid="CR52">52</xref>
]. Another current view is that normal immunity is perturbed by EBV infection and the generation of anti-EBNA-1 antibodies. Those particular anti-EBNA-1 antibodies that also bind lupus-specific autoantigens (Sm or Ro) are followed by the development of more complex autoimmune responses, culminating in clinical disease [
<xref ref-type="bibr" rid="CR47">47</xref>
,
<xref ref-type="bibr" rid="CR48">48</xref>
].</p>
<p>Another notable association is the development of SLE in patients with HCV and Parvo B19 infection [
<xref ref-type="bibr" rid="CR7">7</xref>
]. Attempts to associate parvovirus B19 to SLE have been frustrated [
<xref ref-type="bibr" rid="CR53">53</xref>
]; however, acute infections with parvovirus 19 has been associated with disease flare-up [
<xref ref-type="bibr" rid="CR54">54</xref>
,
<xref ref-type="bibr" rid="CR55">55</xref>
]. Several similarities can be found between the features of SLE and acute Parvo B19 infection, including malar rash, arthralgia and arthritis, fever, fatigue, lymphadenopathy, as well as serological markers. The chronic course of SLE as opposed to the self-limited presentation of parvo B10 infection distinguishes these two diseases. Regarding CMV, in a study of 22 female patients with SLE, evaluating the presence and quantity of human CMV genome, the authors found the virus genome in 100% of the patients, whereas it was present only in 73% of 15 healthy female controls (
<italic>p</italic>
 = 0.02) [
<xref ref-type="bibr" rid="CR56">56</xref>
]. The cumulative evidence for a causal effect of infections on SLE remains to be proved, with the exception of the aforementioned extensive data regarding EBV. Experimental models of induction by infection</p>
<p>It was recently shown that the EBV latent membrane protein 2A, which effects development and activation of B cells, induces hypersensitivity of Toll-like receptor (TLR) stimulation in B cells. B cells are known bearers of TLRs, and this might suggest a mechanistic link between EBV infection and SLE [
<xref ref-type="bibr" rid="CR57">57</xref>
]. A study showed that immunization with the structural CMV pp65 antigen, induced lupus-associated autoantibodies and severe glomerulonephritis [
<xref ref-type="bibr" rid="CR58">58</xref>
].</p>
</sec>
<sec id="Sec19">
<title>Experimental Models of Protection by Infection</title>
<p>One study reported that idiotypic-induced experimental lupus ameliorated the disease severity with the infection with BM5 murine leukemia virus (MuLV) [
<xref ref-type="bibr" rid="CR59">59</xref>
]. This model explores the possible interaction between SLE and retroviral infection, as HIV infection has been cogitated to have a beneficial immunological impact over disease activity of SLE [
<xref ref-type="bibr" rid="CR59">59</xref>
].</p>
</sec>
<sec id="Sec20">
<title>Vaccination</title>
<p>Although the induction of experimental SLE has been reported in mice treated with pristane [
<xref ref-type="bibr" rid="CR60">60</xref>
] and other hydrocarbon oil adjuvant used in vaccines [
<xref ref-type="bibr" rid="CR61">61</xref>
], recent case control studies on SLE patients failed to demonstrate a role for HBV vaccination on disease development or for influenza vaccination on disease activity or antibody production [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
</sec>
</sec>
<sec id="Sec21">
<title>Atherosclerosis</title>
<sec id="Sec22">
<title>Clinical Associations with Infections</title>
<p>Atherosclerosis bears an inflammatory/immune basis and affects up to 20% of the developed world population. The first infection to be associated to atherosclerosis was
<italic>Chlamydophila pneumoniae</italic>
(formerly known as
<italic>Chlamydia pneumoniae</italic>
). In retrospective studies, a positive association was found between antibodies against this pathogen and documented atherosclerosis [
<xref ref-type="bibr" rid="CR62">62</xref>
], but more recent meta-analysis have not confirmed it [
<xref ref-type="bibr" rid="CR63">63</xref>
]. Similar conflicting results have been reported for the association with CMV [
<xref ref-type="bibr" rid="CR64">64</xref>
]. One association that has been consistent in the literature is with periodontitis, which has an important infectious component. Certain periodontal microorganisms, such as
<italic>Campylobacter rectus</italic>
and
<italic>Peptostreptococcus micros</italic>
, are associated to higher degrees of carotid intima-medial wall thickness, an ultrasonographic measure of atherosclerosis [
<xref ref-type="bibr" rid="CR65">65</xref>
].
<italic>Porphyromonas gengivalis</italic>
, a prominent component of oral flora, has also been implicated in atherosclerosis (see below). Other microorganisms, such as
<italic>H. pylori</italic>
, herpes simplex virus, hepatitis A, mycoplasma, influenza virus, and other members of the herpes family have been associated to atherosclerosis but with weaker associations [
<xref ref-type="bibr" rid="CR66">66</xref>
].</p>
</sec>
<sec id="Sec23">
<title>Experimental Models of Induction by Infection</title>
<p>Molecular mimicry has been found between CMV proteins and with heat shock protein 60, an important antigen in the atherosclerotic process [
<xref ref-type="bibr" rid="CR67">67</xref>
]. Accordingly, the experimental infection with murine cytomegalovirus (MCMV) and even after its inactivation aggravates atherosclerosis in a mouse model [
<xref ref-type="bibr" rid="CR68">68</xref>
]. In line with the data linking periodontitis with atherosclerosis,
<italic>P. gingivalis</italic>
infection has been shown to accelerate atherosclerosis in Apo E null mice [
<xref ref-type="bibr" rid="CR69">69</xref>
].</p>
</sec>
<sec id="Sec24">
<title>Experimental Models of Protection by Infection</title>
<p>In line with more recent epidemiological data, experimental
<italic>Chlamydia pneumoniae</italic>
infection has not been shown to aggravate atherosclerosis in wild-type neither in Apo E null mice [
<xref ref-type="bibr" rid="CR70">70</xref>
]. Similarly, pneumococcal immunization has been found to decrease atherosclerosis in a mouse model [
<xref ref-type="bibr" rid="CR71">71</xref>
].</p>
</sec>
</sec>
<sec id="Sec25">
<title>Antiphospholipid Syndrome</title>
<sec id="Sec26">
<title>Clinical Associations with Infections</title>
<p>Antiphospholipid antibodies are clearly associated with several infections, ranging from viral, bacterial, and parasitic infections. In a recent work, the main infections and agents associated to antiphospholipid syndrome (APS) were skin infection, representing 18% of the total; HIV (17%); pneumonia (14%); hepatitis C (13%); and urinary tract infection (10%)[
<xref ref-type="bibr" rid="CR63">63</xref>
,
<xref ref-type="bibr" rid="CR72">72</xref>
]. Associations have also been reported between APS and chronic HCV infection [
<xref ref-type="bibr" rid="CR4">4</xref>
], CMV [
<xref ref-type="bibr" rid="CR73">73</xref>
], EBV [
<xref ref-type="bibr" rid="CR74">74</xref>
], mycoplasma, pulmonary tuberculosis, malaria,
<italic>P. carinii</italic>
, and leptospirosis [
<xref ref-type="bibr" rid="CR3">3</xref>
]. One work has showed the increased prevalence of anticardiolpin antibodies from the IgA isotype in patients with HTLV-1-associated spastic paraparesis [
<xref ref-type="bibr" rid="CR75">75</xref>
].</p>
<p>In the APS, our group and others have demonstrated homology between β2 glycoprotein I (β2GPI) and several microbial proteins. After identifying relevant epitopes in the β2GPI molecule, our group searched homologies between these peptides and several microbial proteins in the Swiss Protein database, linking through molecular mimicry a wide range of infections and this autoimmune disease [
<xref ref-type="bibr" rid="CR76">76</xref>
]. More recently, our group has shown the overlapping pattern of antibodies in the sera of rheumatic fever and APS patients, showing anti- β2GPI titers and functional activity in both groups of patients, as well as anti-protein M titers in APS patients, providing data-linking streptococcal-induced autoimmunity and the commonalities of APS and RF, like the heart valve and the CNS involvement [
<xref ref-type="bibr" rid="CR77">77</xref>
].</p>
<p>Regarding the catastrophic antiphospholipid syndrome, infection as a triggering factor has been identified in up to 24% of patients [
<xref ref-type="bibr" rid="CR78">78</xref>
], being an important cause of death in this subset of patients [
<xref ref-type="bibr" rid="CR79">79</xref>
]. Although a clear relationship between anti-phospholipid antibodies and infections exists, no particular microorganism has been consistently found be involved in the disease pathogenesis.</p>
</sec>
<sec id="Sec27">
<title>Experimental Models of Induction by Infection</title>
<p>Through immunization of mice with bacterial and viral peptides, which share homology with β2 domain, raised titers of anti-cardiolipin and anti-β2GPI have been documented [
<xref ref-type="bibr" rid="CR80">80</xref>
].</p>
</sec>
<sec id="Sec28">
<title>Experimental Models of Protection by Infection</title>
<p>To date, no study has been published demonstrating a protective role of infections on the APS.</p>
</sec>
</sec>
<sec id="Sec29">
<title>Polymyositis PM/Dermatomyositis</title>
<sec id="Sec30">
<title>Clinical Associations with Infections</title>
<p>As recently reviewed, PM is more consistently associated to parvovirus B19, HIV, and HTLV-1 [
<xref ref-type="bibr" rid="CR81">81</xref>
]. In a cohort of chronic hepatitis C patients, the occurrence of inflammatory myopahty was in 2 out of 180 individuals [
<xref ref-type="bibr" rid="CR4">4</xref>
]. Serological association with Cox virus (A7, B3, and B4) has been reported in PM and DM patients, raising concern to this agent in this group of diseases [
<xref ref-type="bibr" rid="CR82">82</xref>
]. In a recent cohort study of juvenile DM, no significant serological or molecular correlations were demonstrated with parvovirus B19 [
<xref ref-type="bibr" rid="CR83">83</xref>
].</p>
</sec>
<sec id="Sec31">
<title>Experimental Models of Induction by Infection</title>
<p>The main experimental model of PM is the chronic inflammatory myositis induced by Coxs B1 Tucson, in which viral epitopes have recently been characterized [
<xref ref-type="bibr" rid="CR84">84</xref>
]. In mice experimental infection with the Ross River virus is also able to induce arthritis and myositis [
<xref ref-type="bibr" rid="CR85">85</xref>
]. The experimental infection with
<italic>Trypanosoma cruzi</italic>
induces myocarditis and myositis, and the multiple infections with different strains of this protozoan are able to exacerbate the inflammatory muscular disease [
<xref ref-type="bibr" rid="CR86">86</xref>
].</p>
</sec>
<sec id="Sec32">
<title>Experimental Models of Protection by Infection</title>
<p>To our best knowledge, no experimental models regarding protection of PM/DM by infection has been published.</p>
</sec>
<sec id="Sec33">
<title>Vaccination</title>
<p>BCG vaccination has been associated to the development of dermatomyositis in three case reports [
<xref ref-type="bibr" rid="CR22">22</xref>
].</p>
</sec>
</sec>
<sec id="Sec34">
<title>Systemic Sclerosis</title>
<sec id="Sec35">
<title>Clinical Associations with Infections</title>
<p>An increased occurrence of parvovirus B19 DNA in skin biopsy samples of systemic sclerosis (SSc) patients has been recently reported as compared to healthy controls, particularly for the gene component VP1, which was found in 75% of SSc patients against 53% [
<xref ref-type="bibr" rid="CR87">87</xref>
]. Regarding EBV antibodies, no significant differences have been found between SSc patients and healthy individuals [
<xref ref-type="bibr" rid="CR5">5</xref>
], as opposed to raised titers of antibodies to CMV matrix protein UL83CMV and to
<italic>H. pylori</italic>
found in the sera of SSc patients as compared to the controls [
<xref ref-type="bibr" rid="CR88">88</xref>
,
<xref ref-type="bibr" rid="CR89">89</xref>
].</p>
</sec>
<sec id="Sec36">
<title>Experimental Models of Induction by Infection</title>
<p>Using a library of random peptides and pooled IgG from 90 patients with diffuse and limited SSc, a peptide was identified that reacted with 93% of the IgG sera. Using a database of protein sequences, the authors observed a high homology of this peptide with autoantigens, such as ribonucleoprotein RNP, filarin, cytocrome C, and with the protein UL94 from CMV [
<xref ref-type="bibr" rid="CR90">90</xref>
]. Furthermore, the reacting antibodies induced apoptosis in human endothelial cells culture (HUVEC). Thus, a possible role for CMV infection is proposed in the induction of autoantibodies capable of inducing apoptosis of endothelial cells, at least in vitro, in SSc [
<xref ref-type="bibr" rid="CR90">90</xref>
]. The mechanisms of endothelial cell damage regarding Ssc and atherosclerosis have been recently reviewed [
<xref ref-type="bibr" rid="CR67">67</xref>
]. In mice, experimental
<italic>Mycoplasma hominis</italic>
infection is able to induce autoantibodies associated with SSc [
<xref ref-type="bibr" rid="CR91">91</xref>
].</p>
</sec>
<sec id="Sec37">
<title>Experimental Models of Protection by Infection</title>
<p>No experimental models have been published.</p>
</sec>
</sec>
<sec id="Sec38">
<title>Primary Vasculitis</title>
<p>Primary vasculitis (or vasculitides) is a heterogeneous group of diseases characterized by inflammation of the blood vessel wall, encompassing several disorders according to the size of the affected vessel: Takayasu’s arteritis and giant cell arteritis (predominantly large vessels), Kawasaki syndrome and polyarteritis nodosa (PAN; predomominantly medium vessels), and Wegener’s granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome, Henoch–Schönlein purpura, essential cryoglobulinemia, and cutaneous leukocytoclastic angiitis (predominantly small vessels). Secondary vasculitis are associated with a wide range of viral (hepatitis C and B), bacterial (staphylococcus, ricketsia), fungal, and parasitic infections. The group of vasculitis with an unexplained etiology, which is believed to be autoimmune, is called primary, and its relationships with infections are our main interest. A excellent review on the subject have recently been published [
<xref ref-type="bibr" rid="CR92">92</xref>
].</p>
<sec id="Sec39">
<title>Clinical Associations with Infections</title>
<p>A notable association is the infection by HCV in patients with mixed cryoglobulinemia and other vasculidities [
<xref ref-type="bibr" rid="CR4">4</xref>
]. In a small series of 13 vasculitis patients, no significant serological correlations were found with parvovirus B19 and V9 erythrovirus [
<xref ref-type="bibr" rid="CR93">93</xref>
]. Chlamydia pneumonia, parvovirus B19, and human herpes virus have been suggested to be associated to giant cell arteritis; however, this has not been reproduced [
<xref ref-type="bibr" rid="CR94">94</xref>
]. To date, no specific pathogen has been proposed to explain Takayasu’s arteritis pathophysiology. The first pathogen associated with PAN was hepatitis B virus. After the widespread availability of HBV vaccination, this association has substantially decreased. Besides HBV, HCV, and HIV have also been found in patients with PAN, and several reports suggest that certain bacterial infections, such as
<italic>Streptococcus</italic>
sp.,
<italic>Klebsiella</italic>
sp,
<italic>Pseudomonas</italic>
sp., and
<italic>Yersinia</italic>
sp., may also be associated [
<xref ref-type="bibr" rid="CR92">92</xref>
]. Regarding Wegener’s granulomatosis, inconsistent associations with parvovirus B19, CMV, and in particular, with
<italic>S. aureus</italic>
have been reported [
<xref ref-type="bibr" rid="CR92">92</xref>
]. Kawasaki disease has not been consistently associated to a particular infectious agent, although association have been reported with
<italic>Coxiella burnetti</italic>
, EBV, HIV, B19, varicella zoster virus(VZV), dengue virus, and
<italic>M. pneumoniae</italic>
[
<xref ref-type="bibr" rid="CR92">92</xref>
]. Recently, a controversy regarding the novel human corona virus (HN-CoV) and Kawasaki disease is taking place in the literature [
<xref ref-type="bibr" rid="CR95">95</xref>
]. Beçeht’s disease exhibits the same scientific status of other primary vasculitis: no consistent associations, although the reported ones include, herpes simplex virus (HSV), HCV, B19,
<italic>S. sanguis, C. pneumoniae</italic>
, and HIV [
<xref ref-type="bibr" rid="CR92">92</xref>
]. A quite long list of microorganisms has been associated to Henoch–Schönlein purpura, which comprises
<italic>Streptococcus</italic>
sp,
<italic>M. pneumoniae</italic>
,
<italic>Yersinia</italic>
sp.,
<italic>Legionella</italic>
,
<italic>H. pylori</italic>
, HBV, HBV, VZV, adenovirus, CMV, B19, and M tuberculosis. Recentlty,
<italic>Bartonella hensea</italic>
have been serologically associated to this disease but without independent confirmation yet [
<xref ref-type="bibr" rid="CR96">96</xref>
].</p>
</sec>
<sec id="Sec40">
<title>Experimental Models of Induction by Infection</title>
<p>Transgenic mice deficient for INF-γ or INF-γ receptor, upon experimental infection with murine gamma-herpesvirus 68 (gammaHV68) after a latency period, develop large-cell vasculitis. The same authors characterized the importance of IFN-γ in controlling the reactivation of the gamma-HV68 in mice [
<xref ref-type="bibr" rid="CR97">97</xref>
]. In another model, the intraperitoneal injection of
<italic>Candida albicans</italic>
water soluble fraction prepared from
<italic>C. albicans</italic>
culture supernatant was able to induce coronary arteritis, a hallmark of Kawasaki disease, and has been related to complement activation by the lectin pathway [
<xref ref-type="bibr" rid="CR98">98</xref>
]. In a model of the central nervous system, vasculitis induced by intrathecal injection of
<italic>Streptococcus pneumoniae</italic>
type 3 isolated from a patient with meningoencephalitis, it was shown that the deletion of TGF receptor II in polymorphonuclears favored bacterial clearance and prevents subsequent cerebral vasculitis [
<xref ref-type="bibr" rid="CR99">99</xref>
]. Finally, LPS has recently been shown to aggravate destructive inflammation in a small vessel vasculitis (glomerulonephritis) model induced by anti-myeloperoxidase antibody [
<xref ref-type="bibr" rid="CR100">100</xref>
].</p>
</sec>
<sec id="Sec41">
<title>Experimental Models of Protection by Infection</title>
<p>To date, no experimental models characterizing a protective role of infections in vasculitis have been reported.</p>
</sec>
<sec id="Sec42">
<title>Vaccination</title>
<p>In selected cases, vaccination with HBV, mumps, measles, influenza, and varicella has been associated to primary vasculitis [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
</sec>
</sec>
<sec id="Sec43">
<title>Sjögren’s Syndrome</title>
<sec id="Sec44">
<title>Clinical Associations with Infections</title>
<p>Sjögren’s syndrome (SSj) occurrence has been reported in chronic hepatitis patients [
<xref ref-type="bibr" rid="CR4">4</xref>
]. Coxsackievirus’ RNA was found in salivary biopsies of patients with SSj in increased frequency when compared to the healthy controls; however, this finding has not been confirmed by other authors [
<xref ref-type="bibr" rid="CR101">101</xref>
]. Regarding EBV, SSj patients exhibit significantly higher titers of IgG to EBNA 2 compared to the healthy controls and are associated with pulmonary involvement [
<xref ref-type="bibr" rid="CR5">5</xref>
].</p>
</sec>
<sec id="Sec45">
<title>Experimental Models of Induction by Infection</title>
<p>Using a transgenic strain of B6-Lpr/lpr deficient for
<italic>fas</italic>
(CD95), and important protein in apoptosis induction, authors have shown that the infection with murine CMV induced a chronic sialadenitis resembling SSj [
<xref ref-type="bibr" rid="CR102">102</xref>
]. Similarly, the infection of LP-BM5 murine leukemia virus, inducer of a murine severe immunodeficiency termed murine AIDS, is also able to generate a sialadenitis resembling SSj and also an exocrine pancreatitis, which might provide a model for evaluating the association between SSj and type 1 diabetes [
<xref ref-type="bibr" rid="CR103">103</xref>
].</p>
</sec>
<sec id="Sec46">
<title>Experimental Models of Protection by Infection</title>
<p>To our best knowledge, no experimental models have been reported regarding protection of SSj by infection.</p>
</sec>
</sec>
<sec id="Sec47">
<title>Autoimmune Thyroid Diseases</title>
<sec id="Sec48">
<title>Clinical Associations with Infections</title>
<p>The infection by
<italic>Yersinia enterocolitica</italic>
has been hypothesized to be linked to autoimmune thyroid diseases, both Graves’ and Hashimoto’s diseases [
<xref ref-type="bibr" rid="CR104">104</xref>
]; however, conflicting data regarding the high prevalence of this infection in the healthy population weakens this hypothesis [
<xref ref-type="bibr" rid="CR105">105</xref>
,
<xref ref-type="bibr" rid="CR106">106</xref>
]. The efforts to associate Graves’ and Hashimoto’s thyroiditis to retroviruses have generated conflicting data: They have been observed in chronic HCV infection and more consistently with IFN-α treatment [
<xref ref-type="bibr" rid="CR107">107</xref>
]. Recent data point to a prominent role of IFN-α therapy in the induction of thyroid autoimmunity in association to HCV infection [
<xref ref-type="bibr" rid="CR108">108</xref>
]. Also, subclinical hypothyroidism has been observed in individuals with HIV infection, particularly those under highly active retroviral therapy, but no thyroid autoimmunity has been detected in these patients [
<xref ref-type="bibr" rid="CR108">108</xref>
].</p>
</sec>
<sec id="Sec49">
<title>Experimental Models of Induction by Infection</title>
<p>An important role of both Th1 and Th2 cytokines has been demonstrated for the development of hyperthyroidism through infection with a transgenic adenovirus bearing thyroid-stimulating hormone (TSH) receptor, reviewing the notion that this disease might solely depend upon Th1 cytokines [
<xref ref-type="bibr" rid="CR109">109</xref>
]. The same group has recently shown the importance of CD25
<sup>+</sup>
CD4
<sup>+</sup>
regulatory T cells (Tregs) in this disease through depletion of Tregs caused enhancement of disease severity [
<xref ref-type="bibr" rid="CR110">110</xref>
]. It has been shown that Hashimoto’s thyroiditis exhibit thyrocytes with overexpressed Toll like receptor 3 (TLR3), an important receptor for pathogen associated molecular patterns (PAMPs) such as dsRNA. It has also been shown that infection with Influenza virus, a single strand RNA virus, is an activator of TLR3 dependent cascades in murine thyrocytes culture, linking the innate immune response observed in Hashimoto’s thyroiditis and infectious stimuli like influenza A virus [
<xref ref-type="bibr" rid="CR111">111</xref>
].</p>
</sec>
<sec id="Sec50">
<title>Experimental Models of Protections by Infection</title>
<p>Schistosoma mansoni experimental infection protected mice from experimental Graves’ disease induced by transgenic adenovirus bearing THS receptor [
<xref ref-type="bibr" rid="CR112">112</xref>
].</p>
</sec>
</sec>
<sec id="Sec51">
<title>Myocarditis, Dilated Cardiomyopahty, and Chagas’s Disease</title>
<p>One of the most studied cases of autoimmunity and parasitic infection is Chagas’ disease chronic cardiomyopathy (CMP), in which infection by
<italic>T. cruzi</italic>
is believed to induce, through several mechanisms of inflammatory and autoimmune response, damage to the heart. This process in the long-term leads the infected patient to a syndrome of dilated CMP and heart failure provoked by antibodies and T cells directed toward heart proteins, which has been shown to share degrees of homology with
<italic>T. cruzi</italic>
proteins [
<xref ref-type="bibr" rid="CR113">113</xref>
].</p>
<sec id="Sec52">
<title>Clinical Associations with Infections</title>
<p>Several infectious agents have been serologically and molecularly associated with myocarditis and dilated CMP, with a high variability of results according to the author. The microorganisms reported include parvovirus B19, Cox B, CMV, EBV, adenovirus, influenza, HBV, HCV, poliovirus, mumps, HIV, respiratory syncytial virus, varicella, streptococcus, tuberculosis, staphylococcus, toxoplasma, plasmodium,
<italic>B. burgdoferi</italic>
, syphilis, and leptospirosis [
<xref ref-type="bibr" rid="CR114">114</xref>
]. More recently, an isolated case of a patient with myopericarditis and
<italic>Campylobacter</italic>
sp. enteritis has been reported [
<xref ref-type="bibr" rid="CR115">115</xref>
].</p>
</sec>
<sec id="Sec53">
<title>Experimental Models of Induction by Infection</title>
<p>Several mouse models demonstrate the role of Cox B3-inducing myocarditis [
<xref ref-type="bibr" rid="CR116">116</xref>
], including transgenic animal models [
<xref ref-type="bibr" rid="CR117">117</xref>
]. It has been shown that the stimulation of toll-like receptor 4 favors the overture of myocarditis induced by Cox B in a model where the transgenic expression of TGF-β in the pancreas initially protected mice from develop myocarditis, reinforcing the multiple steps in disease induction [
<xref ref-type="bibr" rid="CR118">118</xref>
]. Also, the occurrence of myocarditis with the experimental infection with MCMV and encephalomyocarditis virus has been reported [
<xref ref-type="bibr" rid="CR119">119</xref>
].</p>
</sec>
<sec id="Sec54">
<title>Experimental Models of Protection by Infection</title>
<p>A number of studies show the protection from myocarditis induced by infection in experimental models through dissecting activation cascades with transgenic mice. However, to date, no models were found regarding the amelioration of myocarditis by infection.</p>
</sec>
<sec id="Sec55">
<title>Vaccination</title>
<p>After smallpox vaccination, myopericarditid has been reported at an incidence of 7.8 cases per 100,000 in the 30 days after vaccination, a rate of 3.6% higher than the expected, suggesting a causal relationship [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
</sec>
</sec>
<sec id="Sec56">
<title>Inflammatory Bowel Disease</title>
<p>Inflammatory bowel disease (IBD) encompass a group of diseases of autoimmune pathophysiology that includes mainly Crohn’s disease (CD) and ulcerative colitis (UC). Both are associated with several infectious agents, and their development has been related to changes in the intestinal resident microflora.</p>
<sec id="Sec57">
<title>Clinical Associations with Infections</title>
<p>IBD has a marked geographic variation, with increased rates in high-socioeconomic-status individuals, who exhibit the lowest enteric infection rates, and an association with the highest rates of multiple sclerosis [
<xref ref-type="bibr" rid="CR120">120</xref>
]. An association has been reported for
<italic>H. pylori</italic>
, with a particular form of CD, the ulcerative colitis-like form, through a PCR method, but a negative association was found with the other forms of CD [
<xref ref-type="bibr" rid="CR121">121</xref>
]. Interestingly, IBD patients were found to have lower levels of antibodies against
<italic>H. pylori</italic>
in comparison to healthy matched controls [
<xref ref-type="bibr" rid="CR122">122</xref>
]. In established CD and UC, after 6–13 years of follow-up, patients are seropositive for
<italic>Yersinia enterocolitica</italic>
infection [
<xref ref-type="bibr" rid="CR123">123</xref>
]. Also, infection with
<italic>Mycobacterium avium paratuberculosis</italic>
(MAP) has been shown to occur at increased rates in patients with CD [
<xref ref-type="bibr" rid="CR124">124</xref>
]. Very recently, molecular mimicry between MAP proteins and self-peptides has been characterized: Cross-reactivity between MAP proteins and a self-peptide gastrointestinal glutathion peroxidase has been reported in 30% of the evaluated patients, proposing a novel autoantigen in this disease [
<xref ref-type="bibr" rid="CR125">125</xref>
]. Infection with other microorganisms such as
<italic>Clostridium difficile</italic>
, CMV, and
<italic>Entamoeba hystolitica</italic>
might also be associated with IBD [
<xref ref-type="bibr" rid="CR126">126</xref>
]. Interestingly, it has been observed that appendectomy because of appendicitis (not incidental) decreases risk for UC, but it might increase the risk for the development of CD [
<xref ref-type="bibr" rid="CR126">126</xref>
]. As recently reviewed, the manipulation of intestinal flora in patients with IBD through the administration of probiotics, i.e., Lactobacilli and Bifidobacteria among others, is a promising field with current clinical trials investigating it [
<xref ref-type="bibr" rid="CR127">127</xref>
].</p>
</sec>
<sec id="Sec58">
<title>Experimental Models of Induction by Infection</title>
<p>It has been shown that intestinal flora is a requirement for the development of IBD in IL-10 deficient mice, as germ-free counterpart mice are resistant to the disease. Interestingly, the monocolonization of given bacterial species is also not sufficient for the overture of enterocolitis [
<xref ref-type="bibr" rid="CR128">128</xref>
].</p>
</sec>
<sec id="Sec59">
<title>Experimental Models of Protection by Infection</title>
<p>The infection with
<italic>Schistosoma mansoni</italic>
or even the administration of its egg has a beneficial role in preventing the colitis provoked by direct intrarectal administration of tri/di-nitrobenzene sulphonic acid (DNBS) [
<xref ref-type="bibr" rid="CR129">129</xref>
]; the same beneficial effect has been shown for tapeworm,
<italic>Hymenolepis diminuta</italic>
, in another experimental model of colitis induced by DNBS, and this effect was dependent on IL-10 [
<xref ref-type="bibr" rid="CR130">130</xref>
]. Also, the oral administration of
<italic>Trichuris sui</italic>
ova to patients with UC was associated with no side effects and clinical efficacy [
<xref ref-type="bibr" rid="CR131">131</xref>
]. Regarding probiotics, the administration of
<italic>Lactobacillus</italic>
and
<italic>Bifidobacterium</italic>
sp. was able to prevent the development of spontaneous colitis in IL-10-deficient mice [
<xref ref-type="bibr" rid="CR128">128</xref>
].</p>
</sec>
</sec>
<sec id="Sec60">
<title>Autoimmune Thrombocytopenic Purpura ITP</title>
<sec id="Sec61">
<title>Clinical Associations with Infections</title>
<p>Several authors have suggested that persistent infections with HIV, HCV, and
<italic>H. pylori</italic>
, are associated with ITP, and several studies have demonstrated improvement of platelet counts with suppression or eradication of infection, suggesting a role of persistent antigen exposure to the pathogenesis of ITP [
<xref ref-type="bibr" rid="CR132">132</xref>
]. In HIV-infected patients, immune platelet destruction has been shown to be associated with the presence of a cross-reactive antibody, recognizing both the conformational structure of HIV-gp-120 and platelet gpIIIa (CD61) [
<xref ref-type="bibr" rid="CR132">132</xref>
]. The role of
<italic>H. pylori</italic>
infection on the development or persistence of ITP and its eradication on platelet counts emerged from several small studies and from prospective clinical trials [
<xref ref-type="bibr" rid="CR133">133</xref>
,
<xref ref-type="bibr" rid="CR134">134</xref>
]. Cross-reactivity between platelet-associated IgG and
<italic>H. pylori</italic>
Cag protein suggests that molecular mimicry may play a key role in the pathogenesis of a subset of ITP patients [
<xref ref-type="bibr" rid="CR132">132</xref>
].</p>
</sec>
<sec id="Sec62">
<title>Experimental Models of Induction by Infection</title>
<p>The experimental infection with lactate dehydrogenase-elevating virus in mice treated with monoclonal autoantibodies against platelet, in smaller doses than those to induce disease, was found to be the trigger for the development of severe thrombocytopenia. The authors further characterized the importance of phagocytosis and INF-γ for the overture of this disease [
<xref ref-type="bibr" rid="CR135">135</xref>
]. Recently, using a phage display library screening from antibodies against glycoprotein IIIa (autoantigen from platelets) of patients with HIV infection and thrombocytopenia, the authors showed that part of the peptides rescued by the antibodies from the phage display library shared a high homology with HIV-1 proteins, which also were shown to inhibit the anti-platelet antibody toxic effect to platelets in vitro [
<xref ref-type="bibr" rid="CR136">136</xref>
].</p>
</sec>
<sec id="Sec63">
<title>Experimental Models of Protection by Infection</title>
<p>No models have been published in this experimental scenario.</p>
</sec>
<sec id="Sec64">
<title>Vaccination</title>
<p>Vaccination with HBV and MMR has been associated with ITP. Acute ITP developed shortly after MMR vaccination in 23 of ~700,000 Finnish children, which together with multiple case reports, led to the establishment of causality [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
</sec>
</sec>
<sec id="Sec65">
<title>Guillain–Barré Syndrome</title>
<sec id="Sec66">
<title>Clinical Associations with Infections</title>
<p>This polyradicular neuropathy has been associated in a more consistent way to
<italic>Campylobacter jejuni</italic>
,
<italic>Haemophilus influenza</italic>
, HIV, and CMV, and it has also been reported less strongly to EBV and
<italic>M. pneumoniae</italic>
[
<xref ref-type="bibr" rid="CR137">137</xref>
]. Although the association between
<italic>C. jejuni</italic>
and Guillain–Barré Syndrome (GBS) has been well documented, the latest estimated incidence of GBS in patients with
<italic>C. jejuni</italic>
enteritis is 1.7:1,000, a rate 77 greater than for the general population [
<xref ref-type="bibr" rid="CR138">138</xref>
]. The association between
<italic>GBS</italic>
and
<italic>H. pylori</italic>
infection has also been reported [
<xref ref-type="bibr" rid="CR139">139</xref>
].</p>
</sec>
<sec id="Sec67">
<title>Experimental Models of Induction by Infection</title>
<p>In susceptible mice, immunization with
<italic>Brucela melitensis</italic>
induced anti-gangliosides antibodies along with flaccid limb weakness. Importantly, these clinical and serological effects were enhanced when compared to mice immunized with
<italic>C. jejuni</italic>
[
<xref ref-type="bibr" rid="CR140">140</xref>
]. In addition,
<italic>C. jejuni</italic>
specific genes for the glycosilation of lipo-oligosacharides have been shown to play an important role in the induction of anti-gangliosides antibodies through molecular mimicry. As the immunization with transgenic
<italic>C. jejuni</italic>
deficient for these genes generated smaller titers of anti-ganglioside antibodies and less weakness in mice, it characterized the importance of those bacterial structures in the induction of pathogenic antibodies [
<xref ref-type="bibr" rid="CR141">141</xref>
].</p>
</sec>
<sec id="Sec68">
<title>Experimental Models of Protection by Infection</title>
<p>To our best knowledge, no experimental models of protection by infection have been published to date.</p>
</sec>
<sec id="Sec69">
<title>Vaccination</title>
<p>The association of influenza vaccination with GBS was documented after the mass inoculation in the USA with the “swine flu” A/New Jersey/8/76 vaccine in 1976–1977. Recipients of this specific vaccine had a relative risk of 7.6 for developing GBS, and an excess of nine cases per million was confirmed [
<xref ref-type="bibr" rid="CR18">18</xref>
]. In a more recent study from the Vaccine Adverse Events Reporting System, which examined all cases of GBS between the years 1991–1999, the relative risk for GBS after influenza vaccination was 4.3 and, for severe GBS, 8.5, compared to adult tetanus–diphteria vaccine control group, suggesting a causal association [
<xref ref-type="bibr" rid="CR142">142</xref>
]. Less strong is the case for the association of GBS and oral poliovaccine. A nationwide vaccination campaign in Finland was associated with a rise in GBS cases; however, some evidence suggested that the initial increase in cases preceded the campaign, and an additional study failed to support this association [
<xref ref-type="bibr" rid="CR18">18</xref>
].</p>
</sec>
</sec>
<sec id="Sec70">
<title>Post-Streptococcal Syndromes: Rheumatic Fever and PANDAS</title>
<sec id="Sec71">
<title>Rheumatic Fever</title>
<p>The prototypical autoimmune disease induced by a bacterial infection is rheumatic heart disease (RHD), which occurs approximately in 1.2% of children after oro-pharyngeal infection with β-hemolytic group A streptococci. Certain class I and II HLA haplotypes have been implicated in the pathogenesis of RHD, which has been shown to involve humoral and cellular immunological components [
<xref ref-type="bibr" rid="CR143">143</xref>
]. Molecular mimicry has been proposed to be responsible for the pathogenesis of the disease, which also shows a degenerate pattern of TCR recognition, as T cell clones infiltrating the heart of patients also responded to M protein when subjected to lymphoproliferative tests [
<xref ref-type="bibr" rid="CR144">144</xref>
]. In addition, RHD has been induced by immunization with the M protein from group A streptococci [
<xref ref-type="bibr" rid="CR145">145</xref>
]. Interestingly, abrogation of the disease was achieved through intranasal administration of protein M epitopes [
<xref ref-type="bibr" rid="CR146">146</xref>
].</p>
</sec>
<sec id="Sec72">
<title>Pediatric Autoimmune Neuropsychiatric Disorders</title>
<p>Recently, a wide spectrum “pediatric autoimmune neuropsychiatric disorders” (PANDAS) has been described as associated with streptococcal infection that can present clinically from Tourette’s syndrome to chorea. PANDAS is related, at least epidemiologically, to group A streptococci infection [
<xref ref-type="bibr" rid="CR147">147</xref>
], and clearance of serum IgG through plasmapheresis and IVIG reposition has been associated with a remarkable clinical improvement of PANDAS [
<xref ref-type="bibr" rid="CR148">148</xref>
]. Anti-basal ganglia antibodies are associated with this disease [
<xref ref-type="bibr" rid="CR149">149</xref>
].</p>
</sec>
<sec id="Sec73">
<title>The Global Picture</title>
<p>In the process of reviewing the literature on the association of infections and autoimmune diseases, a pattern of clinical associations emerges: chronic viral infections, such as EBV and CMV, and chronic bacterial infections, like
<italic>H. pylori</italic>
, are more frequently associated to multiple autoimmune diseases and, indeed, have experimental models confirming their association with induction of autoimmunity. More recently, the disease overture has been found to rely on multiple steps of induction, be it viral persistence, chronic infection of B cells, or viral deja vus.</p>
<p>Several mechanisms have been proposed for the role of infectious agents on the induction of autoimmune diseases. Molecular mimicry or structural homologies between infectious and host components, underlies the patho-mechanism in rheumatic fever, where the M component of the streptococcus membrane share homologies with heart, brain, and joint synovium peptides. In susceptible individuals, this molecular mimicry modifies lymphocytes reactivity in a progressive and chronic fashion that ultimately lead to autoimmune disease. Molecular mimicry is considered a putative mechanism also in GBS, APS, and MS. Epitope spreading or the appearance of a new antibody or the T cell response to different epitopes on the same or on another antigen has been demonstrated in experimental models and human diseases. In SLE, authors demonstrated intermolecular spreading from Sm antigen to RNP reactivity, and in pre-clinical diabetes and in RA studies, intra- and intermolecular spreading has been observed [
<xref ref-type="bibr" rid="CR3">3</xref>
]. In this context, infections could play an important role either through release of sequestered antigens after tissue damage or upregulation of the display of cryptic epitopes under the inflammatory conditions. Bystander activation is another proposed mechanism in which, under the immune milieu where priming of microbial antigen-specific T cell is taking place, potentially self-reactive T cells are activated. Priming of reactive T cells may occur through an additional mechanism. Infectious agents through tissue injury may cause the release of self antigens, which are processed and presented by antigen-presenting cells, leading to priming of self-reactive T cells. Also, superantigenic T cell activation by viral and bacterial products, which can cross-link the T cell receptor and MHC molecule independent of specific antigen recognition, may favor the induction of an autoimmune disease.</p>
<p>It is well known that viral infections commonly produce transient autoimmune responses (usually directed against blood cells), transient elevation in autoantibodies titers, and arthritis (Parvo B19, rubella). For the vast majority of patients, symptoms and antibody titers decline. Even in cases where the role of microorganisms is well defined, like in rheumatic fever and
<italic>Streptococcus pneumoniae</italic>
groups A, only about 1.2% of infected children actually develop rheumatic fever. Therefore, rather than focusing on the presence or absence of a microorganism in the context of an autoimmune disease, it is the complex immunopathological interaction between the organism and microorganisms, which is the most important factor for the development of an acute infection, for the restoration of health or for the development of a chronic state or an autoimmune disease. This interaction relies in a multitude of factors that include genetic, epigenetic, behavioral, and symbolic factors, as discussed in a recent published book [
<xref ref-type="bibr" rid="CR150">150</xref>
].</p>
<p>Caution should be applied in the leap from experimental models of autoimmune disease induced by infections to clinical disease, as in the experimental models, illness occurs only in particular circumstances such as in susceptible strains, under particular environmental conditions, and with the usage of adjuvant molecules. Furthermore, the widespread genetic manipulation of animals and molecules are commonplace in these models. With the help of experimental models, eventually, genetic determinants and pathways are revealed, but often, other determinants remain unclear. It should be acknowledged that diabetes in NOD mice occurs in 90% of females maintained in specific pathogen-free environment and that it decreases to less than 5% in more conventional (dirtier) environments [
<xref ref-type="bibr" rid="CR41">41</xref>
].</p>
<p>Regarding protection from autoimmune diseases by infections, it seems that the ‘old friends,’ i.e., helminthes, lactobacilli, bifidobacteria, and saprophytic bacteria from the resident flora, are associated with the inhibition of autoimmune diseases, both in experimental and clinical setting. At present, clinical trials are being conducted with these microorganisms.</p>
<p>The amount of data accumulated regarding infections and autoimmune diseases is vast and expanding. Maybe what is needed now is a clearer definition of an immunological physiology and, then, its pathological deviations. For that, we need a new conceptual framework with different approaches and tools that can already be seen in many areas of biology, collectively named ‘system’s biology.’ Hence, we might reach a clearer understanding of the healthy organism, and its pathological deviations, like infections and autoimmune diseases. Specially, because, today, the concept of ‘super-organism’ arises from the deeper layers of biology, the fact that we are composed of bacteria and retroviruses, as evidenced from our genome and microbiome analysis, revealing that host and microorganisms are yoked into a chimera of sorts [
<xref ref-type="bibr" rid="CR151">151</xref>
].</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>This study was supported by the Wilhelm Agricola Research Grant, Federico Foundation, Zurich, Switzerland.</p>
</fn>
</fn-group>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nutton</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>The fatal embrace: Galen and the history of ancient medicine</article-title>
<source>Sci Context</source>
<year>2005</year>
<volume>18</volume>
<fpage>111</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1017/S0269889705000384</pub-id>
<pub-id pub-id-type="pmid">16075496</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Flora</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Quaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bennicelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vercelli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The epidemiological revolution of the 20th century</article-title>
<source>FASEB J</source>
<year>2005</year>
<volume>19</volume>
<fpage>892</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.1096/fj.04-3541rev</pub-id>
<pub-id pub-id-type="pmid">15923399</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<source>Infection and autoimmunity</source>
<year>2004</year>
<edition>1</edition>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Casals</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jara</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases</article-title>
<source>J Intern Med</source>
<year>2005</year>
<volume>257</volume>
<fpage>549</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2796.2005.01490.x</pub-id>
<pub-id pub-id-type="pmid">15910559</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamazaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kusano</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein–Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren’s syndrome patients with pulmonary involvements</article-title>
<source>Clin Exp Immunol</source>
<year>2005</year>
<volume>139</volume>
<fpage>558</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2249.2004.02704.x</pub-id>
<pub-id pub-id-type="pmid">15730403</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Pender</surname>
<given-names>MP</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Epstein–Barr virus and autoimmunity</article-title>
<source>Infection and autoimmunity</source>
<year>2004</year>
<edition>1</edition>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Severin</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Parvovirus B19 infection and its association with autoimmune disease</article-title>
<source>Infection and autoimmunity</source>
<year>2004</year>
<edition>1</edition>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundqvist</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Isa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tolfvenstam</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kvist</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Broliden</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients</article-title>
<source>J Clin Virol</source>
<year>2005</year>
<volume>33</volume>
<fpage>71</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcv.2004.11.011</pub-id>
<pub-id pub-id-type="pmid">15797368</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subair</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tiwana</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fielder</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevation in anti-proteus antibodies in patients with rheumatoid arthritis from Bermuda and England</article-title>
<source>J Rheumatol</source>
<year>1995</year>
<volume>22</volume>
<fpage>1825</fpage>
<lpage>1828</lpage>
<pub-id pub-id-type="pmid">8991977</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newkirk</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Goldbach-Mansky</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Senior</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Klippel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>HR</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>El-Gabalawy</surname>
<given-names>HS</given-names>
</name>
</person-group>
<article-title>Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis</article-title>
<source>Rheumatology (Oxford, England)</source>
<year>2005</year>
<volume>44</volume>
<fpage>1433</fpage>
<lpage>1441</lpage>
<pub-id pub-id-type="doi">10.1093/rheumatology/kei036</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshitomi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Tagami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sakihama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Akira</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice</article-title>
<source>JEM</source>
<year>2005</year>
<volume>201</volume>
<fpage>949</fpage>
<lpage>960</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20041758</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shibuya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kameta</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kameyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tahara-Hanaoka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sumida</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shibuya</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice</article-title>
<source>Immunology</source>
<year>2006</year>
<volume>118</volume>
<fpage>233</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2567.2006.02361.x</pub-id>
<pub-id pub-id-type="pmid">16771858</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinones</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Jimenez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CC chemokine receptor (CCR)-2 prevents arthritis development following infection by
<italic>Mycobacterium avium</italic>
</article-title>
<source>J Mol Med (Berlin, Germany)</source>
<year>2006</year>
<volume>84</volume>
<fpage>503</fpage>
<lpage>512</lpage>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamanishi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Iizumi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Implications for induction of autoimmunity via activation of B-1 cells by
<italic>Helicobacter pylori</italic>
urease</article-title>
<source>Infect Immun</source>
<year>2006</year>
<volume>74</volume>
<fpage>248</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.74.1.248-256.2006</pub-id>
<pub-id pub-id-type="pmid">16368978</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rocha</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Protective role of helminthiasis in the development of autoimmune diseases</article-title>
<source>Clin Dev Immunol</source>
<year>2006</year>
<volume>13</volume>
<fpage>159</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1080/17402520600876895</pub-id>
<pub-id pub-id-type="pmid">17162358</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Endo-Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yokokura</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice</article-title>
<source>Life Sci</source>
<year>1998</year>
<volume>63</volume>
<fpage>635</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.1016/S0024-3205(98)00315-4</pub-id>
<pub-id pub-id-type="pmid">9718093</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costalonga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hodges</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Herzberg</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>
<italic>Streptococcus sanguis</italic>
modulates type II collagen-induced arthritis in DBA/1J mice</article-title>
<source>J Immunol</source>
<year>2002</year>
<volume>169</volume>
<fpage>2189</fpage>
<lpage>2195</lpage>
<pub-id pub-id-type="pmid">12165549</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schattner</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Cosequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines</article-title>
<source>Vaccine</source>
<year>2005</year>
<volume>23</volume>
<fpage>3876</fpage>
<lpage>3886</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2005.03.005</pub-id>
<pub-id pub-id-type="pmid">15917108</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tishler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Vaccination may be associated with autoimmune diseases</article-title>
<source>IMAJ</source>
<year>2004</year>
<volume>6</volume>
<fpage>430</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="pmid">15274537</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tinazzi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ficarra</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Simeoni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Artibani</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lunardi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review</article-title>
<source>Rheumatol Int</source>
<year>2006</year>
<volume>26</volume>
<fpage>481</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1007/s00296-005-0059-2</pub-id>
<pub-id pub-id-type="pmid">16220289</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasudev</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zacharisen</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>New onset rheumatoid arthritis after anthrax vaccination</article-title>
<source>Ann Allergy Asthma Immun</source>
<year>2006</year>
<volume>97</volume>
<fpage>110</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1016/S1081-1206(10)61379-8</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Aron-Maor</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Vaccination and autoimmunity—‘vaccinosis’: a dangerous liaison?</article-title>
<source>J Autoimmun</source>
<year>2000</year>
<volume>14</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1006/jaut.1999.0346</pub-id>
<pub-id pub-id-type="pmid">10648110</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLorenze</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Munger</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Lennette</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Orentreich</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vogelman</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ascherio</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up</article-title>
<source>Arch Neurol</source>
<year>2006</year>
<volume>63</volume>
<fpage>839</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.63.6.noc50328</pub-id>
<pub-id pub-id-type="pmid">16606758</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levin</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Munger</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Rubertone</surname>
<given-names>MV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis</article-title>
<source>J Am Med Assoc</source>
<year>2005</year>
<volume>293</volume>
<fpage>2496</fpage>
<lpage>2500</lpage>
<pub-id pub-id-type="doi">10.1001/jama.293.20.2496</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haahr</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hollsberg</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis is linked to Epstein–Barr virus infection</article-title>
<source>Rev Med Virol</source>
<year>2006</year>
<volume>16</volume>
<fpage>297</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1002/rmv.503</pub-id>
<pub-id pub-id-type="pmid">16927411</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagos</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Nikolopoulos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ioannidis</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis</article-title>
<source>Mult Scler (Houndmills, Basingstoke, England)</source>
<year>2006</year>
<volume>12</volume>
<fpage>397</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1191/1352458506ms1291oa</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kissler</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Is multiple sclerosis caused by a silent infection with malarial parasites? A historico-epidemiological approach: part I</article-title>
<source>Med Hypotheses</source>
<year>2001</year>
<volume>57</volume>
<fpage>280</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1054/mehy.2001.1276</pub-id>
<pub-id pub-id-type="pmid">11516218</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubio</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sanz-Rodriguez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lipton</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Theiler’s virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains</article-title>
<source>Cell Immunol</source>
<year>2006</year>
<volume>239</volume>
<fpage>31</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellimm.2006.03.003</pub-id>
<pub-id pub-id-type="pmid">16684516</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croxford</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Anger</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis</article-title>
<source>J Virol</source>
<year>2005</year>
<volume>79</volume>
<fpage>8581</fpage>
<lpage>8590</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.79.13.8581-8590.2005</pub-id>
<pub-id pub-id-type="pmid">15956599</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merkler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bruck</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zinkernagel</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Del la Torre</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Pinschewer</surname>
<given-names>DD</given-names>
</name>
</person-group>
<article-title>“Viral deja vu” elicits organ-specific immune disease independent of reactivity to self</article-title>
<source>J Clin Invest</source>
<year>2006</year>
<volume>116</volume>
<fpage>1254</fpage>
<lpage>1263</lpage>
<pub-id pub-id-type="doi">10.1172/JCI27372</pub-id>
<pub-id pub-id-type="pmid">16604192</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oldstone</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>von Herrath</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Horwitz</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis</article-title>
<source>Curr Top Microbiol Immunol</source>
<year>1996</year>
<volume>206</volume>
<fpage>67</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">8608726</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westall</surname>
<given-names>FC</given-names>
</name>
</person-group>
<article-title>Molecular mimicry revisited: gut bacteria and multiple sclerosis</article-title>
<source>J Clin Microbiol</source>
<year>2006</year>
<volume>44</volume>
<fpage>2099</fpage>
<lpage>2104</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.02532-05</pub-id>
<pub-id pub-id-type="pmid">16757604</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohindru</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Initial capsid-specific CD4(+) T cell responses protect against Theiler’s murine encephalomyelitisvirus-induced demyelinating disease</article-title>
<source>Eur J Immunol</source>
<year>2006</year>
<volume>36</volume>
<fpage>2106</fpage>
<lpage>2115</lpage>
<pub-id pub-id-type="doi">10.1002/eji.200535785</pub-id>
<pub-id pub-id-type="pmid">16761311</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCoy</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tsunoda</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Fujinami</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation</article-title>
<source>Autoimmunity</source>
<year>2006</year>
<volume>39</volume>
<fpage>9</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1080/08916930500484799</pub-id>
<pub-id pub-id-type="pmid">16455578</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Callis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rynda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haddad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pascual</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine</article-title>
<source>J Immunol</source>
<year>2005</year>
<volume>175</volume>
<fpage>6733</fpage>
<lpage>6740</lpage>
<pub-id pub-id-type="pmid">16272329</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sewell</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Reinke</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Co</surname>
<given-names>DO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis</article-title>
<source>Clin Diagn Lab Immunol</source>
<year>2003</year>
<volume>10</volume>
<fpage>564</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.1128/CDLI.10.4.564-572.2003</pub-id>
<pub-id pub-id-type="pmid">12853387</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Casabonne</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies</article-title>
<source>Diabet Med</source>
<year>2004</year>
<volume>21</volume>
<fpage>507</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1111/j.1464-5491.2004.01182.x</pub-id>
<pub-id pub-id-type="pmid">15154932</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filippi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>von Herrath</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>How viral infections affect the autoimmune process leading to type 1 diabetes</article-title>
<source>Cell Immunol</source>
<year>2005</year>
<volume>233</volume>
<fpage>125</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellimm.2005.04.009</pub-id>
<pub-id pub-id-type="pmid">15963965</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Jun</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>JW</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Viral Infections and type1 diabetes</article-title>
<source>Infection and autoimmunity</source>
<year>2004</year>
<edition>1</edition>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
<fpage>229</fpage>
<lpage>249</lpage>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altobelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Petrocelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Verrotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Valenti</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Infections and risk of type I diabetes in childhood: a population-based case-control study</article-title>
<source>Eur J Epidemiol</source>
<year>2003</year>
<volume>18</volume>
<fpage>425</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1023/A:1024256305963</pub-id>
<pub-id pub-id-type="pmid">12889689</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ilic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koelsch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sarvetnick</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Homeostatic expansion of T cells during immune insufficiency generates autoimmunity</article-title>
<source>Cell</source>
<year>2004</year>
<volume>117</volume>
<fpage>265</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(04)00335-6</pub-id>
<pub-id pub-id-type="pmid">15084263</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gronski</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Boulter</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Moskophidis</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TCR affinity and negative regulation limit autoimmunity</article-title>
<source>Nat Med</source>
<year>2004</year>
<volume>10</volume>
<fpage>1234</fpage>
<lpage>1239</lpage>
<pub-id pub-id-type="doi">10.1038/nm1114</pub-id>
<pub-id pub-id-type="pmid">15467726</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serreze</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Wasserfall</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ottendorfer</surname>
<given-names>EW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon</article-title>
<source>J Virol</source>
<year>2005</year>
<volume>79</volume>
<fpage>1045</fpage>
<lpage>1052</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.79.2.1045-1052.2005</pub-id>
<pub-id pub-id-type="pmid">15613333</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alyanakian</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Grela</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aumeunier</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes</article-title>
<source>Diabetes</source>
<year>2006</year>
<volume>55</volume>
<fpage>179</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.55.01.06.db05-0189</pub-id>
<pub-id pub-id-type="pmid">16380491</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raine</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zaccone</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mastroeni</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cooke</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes</article-title>
<source>J Immunol</source>
<year>2006</year>
<volume>177</volume>
<fpage>2224</fpage>
<lpage>2233</lpage>
<pub-id pub-id-type="pmid">16887982</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cooke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>CE</given-names>
</name>
</person-group>
<article-title>Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection</article-title>
<source>Infect Immun</source>
<year>2006</year>
<volume>75</volume>
<fpage>397</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00664-06</pub-id>
<pub-id pub-id-type="pmid">17043101</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harley</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>James</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Epstein–Barr virus infection induces lupus autoimmunity</article-title>
<source>Bull Hosp Joint Dis</source>
<year>2006</year>
<volume>64</volume>
<fpage>45</fpage>
<lpage>50</lpage>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harley</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Harley</surname>
<given-names>IT</given-names>
</name>
<name>
<surname>Guthridge</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>James</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The curiously suspicious: a role for Epstein–Barr virus in lupus</article-title>
<source>Lupus</source>
<year>2006</year>
<volume>15</volume>
<fpage>768</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1177/0961203306070009</pub-id>
<pub-id pub-id-type="pmid">17153849</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Neas</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systemic lupus erythematosus in adults is associated with previous Epstein–Barr virus exposure</article-title>
<source>Arthritis Rheum</source>
<year>2001</year>
<volume>44</volume>
<fpage>1122</fpage>
<lpage>1136</lpage>
<pub-id pub-id-type="doi">10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D</pub-id>
<pub-id pub-id-type="pmid">11352244</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parks</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>LL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of Epstein–Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype</article-title>
<source>Arthritis Rheum</source>
<year>2005</year>
<volume>52</volume>
<fpage>1148</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="doi">10.1002/art.20997</pub-id>
<pub-id pub-id-type="pmid">15818712</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>SC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High prevalence of immunoglobulin A antibody against Epstein–Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies</article-title>
<source>J Rheumatol</source>
<year>2005</year>
<volume>32</volume>
<fpage>44</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="pmid">15630723</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mockridge</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buchan</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common patterns of B cell perturbation and expanded V4–34 immunoglobulin gene usage in autoimmunity and infection</article-title>
<source>Autoimmunity</source>
<year>2004</year>
<volume>37</volume>
<fpage>9</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1080/08916930310001624656</pub-id>
<pub-id pub-id-type="pmid">15115306</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bengtsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Widell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elmstahl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sturfelt</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19</article-title>
<source>Ann Rheum Dis</source>
<year>2000</year>
<volume>59</volume>
<fpage>64</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1136/ard.59.1.64</pub-id>
<pub-id pub-id-type="pmid">10627430</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemauer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Beckenlehner</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Modrow</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient</article-title>
<source>J Clin Virol</source>
<year>1999</year>
<volume>14</volume>
<fpage>73</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/S1386-6532(99)00038-4</pub-id>
<pub-id pub-id-type="pmid">10548133</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seishima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yamamura</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Two-year follow-up study after human parvovirus B19 infection</article-title>
<source>Dermatology</source>
<year>2003</year>
<volume>206</volume>
<fpage>192</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1159/000068885</pub-id>
<pub-id pub-id-type="pmid">12673074</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hrycek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kusmierz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mazurek</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Wilczok</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Human cytomegalovirus in patients with systemic lupus erythematosus</article-title>
<source>Autoimmunity</source>
<year>2005</year>
<volume>38</volume>
<fpage>487</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1080/08916930500285667</pub-id>
<pub-id pub-id-type="pmid">16373253</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nicholas</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Conway</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity</article-title>
<source>J Immunol</source>
<year>2006</year>
<volume>177</volume>
<fpage>27932</fpage>
<lpage>802</lpage>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice</article-title>
<source>Clin Exp Immunol</source>
<year>2006</year>
<volume>143</volume>
<fpage>167</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2249.2005.02974.x</pub-id>
<pub-id pub-id-type="pmid">16367948</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mittleman</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Morse</surname>
<given-names>HC</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Payne</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Shearer</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Mozes</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection</article-title>
<source>J Clin Immunol</source>
<year>1996</year>
<volume>16</volume>
<fpage>230</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1007/BF01541229</pub-id>
<pub-id pub-id-type="pmid">8840225</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nacionales</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Akaogi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Reeves</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Satoh</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine</article-title>
<source>Biomed Pharmacother</source>
<year>2004</year>
<volume>58</volume>
<fpage>325</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopha.2004.04.009</pub-id>
<pub-id pub-id-type="pmid">15194169</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Ajmani</surname>
<given-names>AK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane</article-title>
<source>J Immunol</source>
<year>1996</year>
<volume>157</volume>
<fpage>3200</fpage>
<lpage>3206</lpage>
<pub-id pub-id-type="pmid">8816434</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saikku</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leinonen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mattila</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction</article-title>
<source>Lancet</source>
<year>1988</year>
<volume>2</volume>
<fpage>983</fpage>
<lpage>986</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(88)90741-6</pub-id>
<pub-id pub-id-type="pmid">2902492</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danesh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Whincup</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis</article-title>
<source>Eur Heart J</source>
<year>2003</year>
<volume>24</volume>
<fpage>881</fpage>
<pub-id pub-id-type="doi">10.1016/S0195-668X(02)00801-1</pub-id>
<pub-id pub-id-type="pmid">12727159</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degre</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Has cytomegalovirus infection any role in the development of atherosclerosis?</article-title>
<source>Clin Microbiol Infect</source>
<year>2002</year>
<volume>8</volume>
<fpage>191</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1046/j.1469-0691.2002.00407.x</pub-id>
<pub-id pub-id-type="pmid">12047409</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beck</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Eke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults</article-title>
<source>Atherosclerosis</source>
<year>2005</year>
<volume>183</volume>
<fpage>342</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.03.017</pub-id>
<pub-id pub-id-type="pmid">15893320</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Frostegård</surname>
<given-names>J</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Infection and atherosclerosis</article-title>
<source>Infections and autoimmunity</source>
<year>2004</year>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
<fpage>701</fpage>
<lpage>709</lpage>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lunardi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bason</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Corrocher</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Puccetti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Induction of endothelial cell damage by hCMV molecular mimicry</article-title>
<source>Trends Immunol</source>
<year>2005</year>
<volume>26</volume>
<fpage>19</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2004.10.009</pub-id>
<pub-id pub-id-type="pmid">15629405</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vliegen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Herngreen</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Grauls</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Bruggeman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Stassen</surname>
<given-names>FR</given-names>
</name>
</person-group>
<article-title>Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice</article-title>
<source>Atherosclerosis</source>
<year>2005</year>
<volume>181</volume>
<fpage>39</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2004.12.035</pub-id>
<pub-id pub-id-type="pmid">15939052</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lalla</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lamster</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2003</year>
<volume>23</volume>
<fpage>1405</fpage>
<lpage>1411</lpage>
<pub-id pub-id-type="doi">10.1161/01.ATV.0000082462.26258.FE</pub-id>
<pub-id pub-id-type="pmid">12816879</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caligiuri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rottenberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wigzell</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hansson</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice</article-title>
<source>Circulation</source>
<year>2001</year>
<volume>103</volume>
<fpage>2834283</fpage>
<lpage>2834288</lpage>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Binder</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Horkko</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dewan</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between
<italic>Streptococcus pneumoniae</italic>
and oxidized LDL</article-title>
<source>Nat Med</source>
<year>2003</year>
<volume>9</volume>
<fpage>736</fpage>
<lpage>743</lpage>
<pub-id pub-id-type="doi">10.1038/nm876</pub-id>
<pub-id pub-id-type="pmid">12740573</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cervera</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Acevedo</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients</article-title>
<source>Ann Rheum Dis</source>
<year>2004</year>
<volume>63</volume>
<fpage>1312</fpage>
<lpage>1317</lpage>
<pub-id pub-id-type="doi">10.1136/ard.2003.014175</pub-id>
<pub-id pub-id-type="pmid">15361392</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uthman</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tabbarah</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gharavi</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Hughes syndrome associated with cytomegalovirus infection</article-title>
<source>Lupus</source>
<year>1999</year>
<volume>8</volume>
<fpage>775</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1191/096120399678841034</pub-id>
<pub-id pub-id-type="pmid">10602454</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Hal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Senanayake</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hardiman</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein–Barr virus infection</article-title>
<source>J Clin Virol</source>
<year>2005</year>
<volume>32</volume>
<fpage>245</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcv.2004.07.013</pub-id>
<pub-id pub-id-type="pmid">15722031</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faghiri</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Taheri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>OS</given-names>
</name>
<name>
<surname>Gharavi</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis</article-title>
<source>Lupus</source>
<year>1999</year>
<volume>8</volume>
<fpage>210</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1191/096120399678847731</pub-id>
<pub-id pub-id-type="pmid">10342713</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blank</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Cervera</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Antiphospholipid syndrome infectious origin</article-title>
<source>J Clin Immunol</source>
<year>2004</year>
<volume>24</volume>
<fpage>12</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1023/B:JOCI.0000018058.28764.ce</pub-id>
<pub-id pub-id-type="pmid">14997029</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blank</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Magrini</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome</article-title>
<source>Rheumatology (Oxford, England)</source>
<year>2006</year>
<volume>45</volume>
<fpage>833</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="doi">10.1093/rheumatology/kel118</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cervera</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gomez-Puerta</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cucho</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Font</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>“CAPS registry”. A review of 200 cases from the International Registry of patients with the Catastrophic Antiphospholipid Syndrome (CAPS)</article-title>
<source>Ann Rheum Dis</source>
<year>2003</year>
<volume>62</volume>
<issue>Suppl 1</issue>
<fpage>88</fpage>
<pub-id pub-id-type="pmid">12480683</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bucciarelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cervera</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients</article-title>
<source>Arthritis Rheum</source>
<year>2006</year>
<volume>54</volume>
<fpage>2568</fpage>
<lpage>2576</lpage>
<pub-id pub-id-type="doi">10.1002/art.22018</pub-id>
<pub-id pub-id-type="pmid">16868979</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gharavi</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Chaimovich</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cucurull</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides</article-title>
<source>Lupus</source>
<year>1999</year>
<volume>8</volume>
<fpage>449</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="doi">10.1177/096120339900800607</pub-id>
<pub-id pub-id-type="pmid">10483013</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zampieri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghirardello</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iaccarino</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Polymyositis–dermatomyositis and infections</article-title>
<source>Autoimmunity</source>
<year>2006</year>
<volume>39</volume>
<fpage>191</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1080/08916930600622348</pub-id>
<pub-id pub-id-type="pmid">16769652</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishikai</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Coxsackievirus infection and the development of polymyositis/dermatomyositis</article-title>
<source>Rheumatol Int</source>
<year>1994</year>
<volume>14</volume>
<fpage>43</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1007/BF00300245</pub-id>
<pub-id pub-id-type="pmid">7824834</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamyrova</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rider</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Haagenson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Parvovirus B19 and onset of juvenile dermatomyositis</article-title>
<source>J Am Med Assoc</source>
<year>2005</year>
<volume>294</volume>
<fpage>2170</fpage>
<lpage>2171</lpage>
<pub-id pub-id-type="doi">10.1001/jama.294.17.2170</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tam</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Weber-Sanders</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Messner</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy</article-title>
<source>J Virol</source>
<year>2003</year>
<volume>77</volume>
<fpage>11849</fpage>
<lpage>11854</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.77.21.11849-11854.2003</pub-id>
<pub-id pub-id-type="pmid">14557670</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Whitmore</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Shabman</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Lidbury</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Mahalingam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heise</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis</article-title>
<source>J Virol</source>
<year>2006</year>
<volume>80</volume>
<fpage>737</fpage>
<lpage>749</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.80.2.737-749.2006</pub-id>
<pub-id pub-id-type="pmid">16378976</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrade</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Sobral</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Magalhaes</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Guedes</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Guerreiro</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Reinfections with strains of
<italic>Trypanosoma cruzi</italic>
, of different biodemes as a factor of aggravation of myocarditis and myositis in mice</article-title>
<source>Rev Soc Bras Med Trop</source>
<year>2006</year>
<volume>39</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">16501758</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohtsuka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue</article-title>
<source>Br J Dermatol</source>
<year>2005</year>
<volume>152</volume>
<fpage>1078</fpage>
<lpage>1080</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2133.2005.06567.x</pub-id>
<pub-id pub-id-type="pmid">15888183</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Namboodiri</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rocca</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Kuwana</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis</article-title>
<source>Clin Exp Rheumatol</source>
<year>2006</year>
<volume>24</volume>
<fpage>176</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="pmid">16762154</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalabay</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fekete</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Czirjak</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>
<italic>Helicobacter pylori</italic>
infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60</article-title>
<source>Helicobacter</source>
<year>2002</year>
<volume>7</volume>
<fpage>250</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1046/j.1523-5378.2002.00092.x</pub-id>
<pub-id pub-id-type="pmid">12165033</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lunardi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bason</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Navone</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells</article-title>
<source>Nat Med</source>
<year>2000</year>
<volume>6</volume>
<fpage>1183</fpage>
<lpage>1186</lpage>
<pub-id pub-id-type="doi">10.1038/80533</pub-id>
<pub-id pub-id-type="pmid">11017152</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gavanescu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pihan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Halilovic</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Szomolanyi-Tsuda</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Welsh</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Doxsey</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Mycoplasma infection induces a scleroderma-like centrosome autoantibody response in mice</article-title>
<source>Clin Exp Immunol</source>
<year>2004</year>
<volume>137</volume>
<fpage>288</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2249.2004.02535.x</pub-id>
<pub-id pub-id-type="pmid">15270845</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez-Pla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Vasculitis and systemic infections</article-title>
<source>Curr Opin Rheumatol</source>
<year>2006</year>
<volume>18</volume>
<fpage>39</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1097/01.bor.0000197999.58073.2e</pub-id>
<pub-id pub-id-type="pmid">16344618</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eden</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mahr</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Servant</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study</article-title>
<source>Rheumatology (Oxford)</source>
<year>2003</year>
<volume>42</volume>
<fpage>660</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1093/rheumatology/keg206</pub-id>
<pub-id pub-id-type="pmid">12709542</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helweg-Larsen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tarp</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Obel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Baslund</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>No evidence of parvovirus B19,
<italic>Chlamydia pneumoniae</italic>
or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis</article-title>
<source>Rheumatology (Oxford)</source>
<year>2002</year>
<volume>41</volume>
<fpage>445</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1093/rheumatology/41.4.445</pub-id>
<pub-id pub-id-type="pmid">11961176</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>CL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan</article-title>
<source>J Infect Dis</source>
<year>2006</year>
<volume>193</volume>
<fpage>283</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1086/498875</pub-id>
<pub-id pub-id-type="pmid">16362893</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Spady</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>E</given-names>
</name>
<name>
<surname>McColl</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Artsob</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Bartonella seropositivity in children with Henoch–Schonlein purpura</article-title>
<source>BMC Infec Dis</source>
<year>2005</year>
<volume>5</volume>
<issue>1</issue>
<fpage>21</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2334-5-21</pub-id>
<pub-id pub-id-type="pmid">15807903</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steed</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Tibbetts</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gamma interferon blocks gammaherpesvirus reactivation from latency</article-title>
<source>J Virol</source>
<year>2006</year>
<volume>80</volume>
<fpage>192</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.80.1.192-200.2006</pub-id>
<pub-id pub-id-type="pmid">16352543</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinohara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nagi-Miura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Beta-mannosyl linkages negatively regulate anaphylaxis and vasculitis in mice, induced by CAWS, fungal PAMPS composed of mannoprotein-beta-glucan complex secreted by
<italic>Candida albicans</italic>
</article-title>
<source>Biol Pharm Bull</source>
<year>2006</year>
<volume>29</volume>
<fpage>1854</fpage>
<lpage>1861</lpage>
<pub-id pub-id-type="doi">10.1248/bpb.29.1854</pub-id>
<pub-id pub-id-type="pmid">16946498</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malipiero</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Koedel</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Pfister</surname>
<given-names>HW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis</article-title>
<source>Brain</source>
<year>2006</year>
<volume>129</volume>
<issue>Pt 9</issue>
<fpage>2404</fpage>
<lpage>2415</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awl192</pub-id>
<pub-id pub-id-type="pmid">16891635</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huugen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van Esch</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha</article-title>
<source>Am J Pathol</source>
<year>2005</year>
<volume>167</volume>
<fpage>47</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">15972951</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gottenberg</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Pallier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ittah</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Failure to confirm coxsackievirus infection in primary Sjogren's syndrome</article-title>
<source>Arthritis Rheum</source>
<year>2006</year>
<volume>54</volume>
<fpage>2026</fpage>
<lpage>2028</lpage>
<pub-id pub-id-type="doi">10.1002/art.21906</pub-id>
<pub-id pub-id-type="pmid">16732567</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleck</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mountz</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Murine cytomegalovirus induces a Sjogren’s syndrome-like disease in C57Bl/6-lpr/lpr mice</article-title>
<source>Arthritis Rheum</source>
<year>1998</year>
<volume>41</volume>
<fpage>2175</fpage>
<lpage>2184</lpage>
<pub-id pub-id-type="doi">10.1002/1529-0131(199812)41:12<2175::AID-ART12>3.0.CO;2-I</pub-id>
<pub-id pub-id-type="pmid">9870874</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kawauchi</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus</article-title>
<source>Clin Immunol</source>
<year>2003</year>
<volume>109</volume>
<fpage>212</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1016/S1521-6616(03)00197-9</pub-id>
<pub-id pub-id-type="pmid">14597220</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corapcioglu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tonyukuk</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kiyan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies</article-title>
<source>Thyroid</source>
<year>2002</year>
<volume>12</volume>
<fpage>613</fpage>
<lpage>617</lpage>
<pub-id pub-id-type="doi">10.1089/105072502320288483</pub-id>
<pub-id pub-id-type="pmid">12193307</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maki-Ikola</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Heesemann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Toivanen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Granfors</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>High frequency of Yersinia antibodies in healthy populations in Finland and Germany</article-title>
<source>Rheumatol Int</source>
<year>1997</year>
<volume>16</volume>
<fpage>227</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1007/BF01375653</pub-id>
<pub-id pub-id-type="pmid">9106932</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Wenzel</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Brix</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Hegedus</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study</article-title>
<source>Clin Exp Immunol</source>
<year>2006</year>
<volume>146</volume>
<fpage>32</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03183.x</pub-id>
<pub-id pub-id-type="pmid">16968395</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandac</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Chaudhry</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Tomer</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification</article-title>
<source>Hepatology (Baltimore)</source>
<year>2006</year>
<volume>43</volume>
<fpage>661</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="pmid">16557537</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Coiro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Valli</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Graves’ disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection</article-title>
<source>J Investig Med</source>
<year>2005</year>
<volume>53</volume>
<fpage>26</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.2310/6650.2005.00002</pub-id>
<pub-id pub-id-type="pmid">16025878</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagayama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Saitoh</surname>
<given-names>O</given-names>
</name>
<name>
<surname>McLachlan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kumazawa</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>TSH receptor-adenovirus-induced Graves’ hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm</article-title>
<source>Clin Exp Immunol</source>
<year>2004</year>
<volume>138</volume>
<fpage>417</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2249.2004.02641.x</pub-id>
<pub-id pub-id-type="pmid">15544617</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saitoh</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nagayama</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Regulation of Graves’ hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model</article-title>
<source>Endocrinology</source>
<year>2006</year>
<volume>147</volume>
<fpage>2417</fpage>
<lpage>2422</lpage>
<pub-id pub-id-type="doi">10.1210/en.2005-1024</pub-id>
<pub-id pub-id-type="pmid">16439459</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harii</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Vasko</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto’s autoimmune thyroiditis</article-title>
<source>Mol Endocrinol (Baltimore)</source>
<year>2005</year>
<volume>19</volume>
<fpage>1231</fpage>
<lpage>1250</lpage>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagayama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McLachlan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves’ hyperthyroidism</article-title>
<source>J Immunol</source>
<year>2004</year>
<volume>173</volume>
<fpage>2167</fpage>
<lpage>2173</lpage>
<pub-id pub-id-type="pmid">15265954</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunha-Neto</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bilate</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Hyland</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kalil</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Engman</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry</article-title>
<source>Autoimmunity</source>
<year>2006</year>
<volume>39</volume>
<fpage>41</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1080/08916930500485002</pub-id>
<pub-id pub-id-type="pmid">16455581</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fairweather</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Inflammatory heart disease: a role for cytokines</article-title>
<source>Lupus</source>
<year>2005</year>
<volume>14</volume>
<fpage>646</fpage>
<lpage>651</lpage>
<pub-id pub-id-type="doi">10.1191/0961203305lu2192oa</pub-id>
<pub-id pub-id-type="pmid">16218459</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotilainen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lehtopolku</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hakanen</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review</article-title>
<source>Scand J Infec Dis</source>
<year>2006</year>
<volume>38</volume>
<issue>6–7</issue>
<fpage>549</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1080/00365540500372903</pub-id>
<pub-id pub-id-type="pmid">16798711</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fairweather</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Frisancho-Kiss</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yusung</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart</article-title>
<source>J Immunol</source>
<year>2005</year>
<volume>174</volume>
<fpage>261</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">15611248</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Core protein of hepatitis C virus induces cardiomyopathy</article-title>
<source>Circ Res</source>
<year>2005</year>
<volume>96</volume>
<fpage>148</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1161/01.RES.0000154263.70223.13</pub-id>
<pub-id pub-id-type="pmid">15618537</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richer</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shanina</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Horwitz</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis</article-title>
<source>Clin Immunol</source>
<year>2006</year>
<volume>121</volume>
<issue>3</issue>
<fpage>339</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2006.07.009</pub-id>
<pub-id pub-id-type="pmid">16963319</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Afanasyeva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Viral infection and heart disease: autoimmune mechanisms</article-title>
<source>Infection and autoimmunity</source>
<year>2004</year>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Beaudoin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>CN</given-names>
</name>
</person-group>
<article-title>A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues</article-title>
<source>Am J Epidemiol</source>
<year>2006</year>
<volume>164</volume>
<fpage>615</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="doi">10.1093/aje/kwj260</pub-id>
<pub-id pub-id-type="pmid">16920784</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Isolation of
<italic>Helicobacter pylori</italic>
from the intestinal mucosa of patients with Crohn’s disease</article-title>
<source>Helicobacter</source>
<year>2006</year>
<volume>11</volume>
<fpage>2</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/j.0083-8703.2006.00368.x</pub-id>
<pub-id pub-id-type="pmid">16423084</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pronai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schandl</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Orosz</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Magyar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tulassay</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Lower prevalence of
<italic>Helicobacter pylori</italic>
infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease—antibiotic use in the history does not play a significant role</article-title>
<source>Helicobacter</source>
<year>2004</year>
<volume>9</volume>
<fpage>278</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1111/j.1083-4389.2004.00223.x</pub-id>
<pub-id pub-id-type="pmid">15165265</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saebo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vik</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Matuszkiewicz</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection</article-title>
<source>Eur J Intern Med</source>
<year>2005</year>
<volume>16</volume>
<fpage>176</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejim.2004.11.008</pub-id>
<pub-id pub-id-type="pmid">15967332</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hamdi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Valentine</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Naser</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Evaluation of surgical tissue from patients with Crohn’s disease for the presence of
<italic>Mycobacterium avium</italic>
subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction</article-title>
<source>Inflamm Bowel Dis</source>
<year>2005</year>
<volume>11</volume>
<fpage>116</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1097/00054725-200502000-00004</pub-id>
<pub-id pub-id-type="pmid">15677904</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polymeros</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bogdanos</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Arioli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vergani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Forbes</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Does cross-reactivity between
<italic>Mycobacterium avium</italic>
paratuberculosis and human intestinal antigens characterize Crohn’s disease?</article-title>
<source>Gastroenterology</source>
<year>2006</year>
<volume>131</volume>
<fpage>85</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2006.04.021</pub-id>
<pub-id pub-id-type="pmid">16831593</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Weinstock</surname>
<given-names>JV</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Inflammatory bowel disease</article-title>
<source>Infection and Autoimmunity</source>
<year>2004</year>
<edition>1</edition>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
<fpage>649</fpage>
<lpage>673</lpage>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gionchetti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rizzello</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lammers</surname>
<given-names>KM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antibiotics and probiotics in treatment of inflammatory bowel disease</article-title>
<source>World J Gastroenterol</source>
<year>2006</year>
<volume>12</volume>
<fpage>3306</fpage>
<lpage>3313</lpage>
<pub-id pub-id-type="pmid">16733845</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sydora</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Tavernini</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Fedorak</surname>
<given-names>RN</given-names>
</name>
</person-group>
<article-title>Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response</article-title>
<source>Dig Dis Sci</source>
<year>2005</year>
<volume>50</volume>
<fpage>905</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="doi">10.1007/s10620-005-2663-0</pub-id>
<pub-id pub-id-type="pmid">15906767</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreels</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Nieuwendijk</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>De Man</surname>
<given-names>JG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats</article-title>
<source>Gut</source>
<year>2004</year>
<volume>53</volume>
<fpage>99</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1136/gut.53.1.99</pub-id>
<pub-id pub-id-type="pmid">14684583</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis</article-title>
<source>J Immunol</source>
<year>2005</year>
<volume>174</volume>
<fpage>7368</fpage>
<lpage>7375</lpage>
<pub-id pub-id-type="pmid">15905584</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Summers</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>JF</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Thompson</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Weinstock</surname>
<given-names>JV</given-names>
</name>
</person-group>
<article-title>
<italic>Trichuris suis</italic>
therapy for active ulcerative colitis: a randomized controlled trial</article-title>
<source>Gastroenterology</source>
<year>2005</year>
<volume>128</volume>
<fpage>825</fpage>
<lpage>832</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2005.01.005</pub-id>
<pub-id pub-id-type="pmid">15825065</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szyper-Kravitz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Thrombocytopenic conditions—autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT and APS</article-title>
<source>Am J Hematol</source>
<year>2005</year>
<volume>80</volume>
<fpage>232</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="doi">10.1002/ajh.20408</pub-id>
<pub-id pub-id-type="pmid">16247748</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsushima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Masui</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of
<italic>Helicobacter pylori</italic>
eradication in patients with chronic idiopathic thrombocytopenic purpura—a randomized controlled trial</article-title>
<source>Am J Gastroenterol</source>
<year>2005</year>
<volume>100</volume>
<fpage>1265</fpage>
<lpage>1270</lpage>
<pub-id pub-id-type="doi">10.1111/j.1572-0241.2005.41641.x</pub-id>
<pub-id pub-id-type="pmid">15929755</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stasi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Stipa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Amadori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Newland</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Provan</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>
<italic>Helicobacter pylori</italic>
eradication in the management of patients with idiopathic thrombocytopenic purpura</article-title>
<source>Am J Med</source>
<year>2005</year>
<volume>118</volume>
<fpage>414</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjmed.2004.09.014</pub-id>
<pub-id pub-id-type="pmid">15808140</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Musaji</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meite</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Detalle</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia</article-title>
<source>Autoimmunity Rev</source>
<year>2005</year>
<volume>4</volume>
<fpage>247</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2004.11.010</pub-id>
<pub-id pub-id-type="pmid">15893720</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Nardi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Karpatkin</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia</article-title>
<source>Blood</source>
<year>2005</year>
<volume>106</volume>
<fpage>572</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2005-01-0243</pub-id>
<pub-id pub-id-type="pmid">15774614</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>van Sorge</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>van de Winkel</surname>
<given-names>JGJ</given-names>
</name>
<name>
<surname>van der Pol</surname>
<given-names>WL</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Shoenfeld</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Infection and Guillain-Barré syndrome</article-title>
<source>Infection and autoimmunity</source>
<year>2004</year>
<publisher-loc>Amsterdam</publisher-loc>
<publisher-name>Elsevier</publisher-name>
<fpage>591</fpage>
<lpage>612</lpage>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tam</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hayward</surname>
<given-names>A</given-names>
</name>
<name>
<surname>O'Brien</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Incidence of Guillain–Barre syndrome among patients with Campylobacter infection: a general practice research database study</article-title>
<source>J Infect Dis</source>
<year>2006</year>
<volume>194</volume>
<fpage>95</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1086/504294</pub-id>
<pub-id pub-id-type="pmid">16741887</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kountouras</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deretzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zavos</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between
<italic>Helicobacter pylori</italic>
infection and acute inflammatory demyelinating polyradiculoneuropathy</article-title>
<source>Eur J Neurol</source>
<year>2005</year>
<volume>12</volume>
<fpage>139</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1111/j.1468-1331.2004.00977.x</pub-id>
<pub-id pub-id-type="pmid">15679702</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nishiguchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Watarai</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Brucella melitensis infection associated with Guillain–Barre syndrome through molecular mimicry of host structures</article-title>
<source>FEMS Iimmunol Med Microbiol</source>
<year>2005</year>
<volume>45</volume>
<fpage>121</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1016/j.femsim.2005.03.001</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godschalk</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Heikema</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The crucial role of
<italic>Campylobacter jejuni</italic>
genes in anti-ganglioside antibody induction in Guillain–Barre syndrome</article-title>
<source>J Clin Invest</source>
<year>2004</year>
<volume>114</volume>
<fpage>1659</fpage>
<lpage>1665</lpage>
<pub-id pub-id-type="pmid">15578098</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geier</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Zahalsky</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Influenza vaccination and Guillain–Barre syndrome</article-title>
<source>Clin Immunol</source>
<year>2003</year>
<volume>107</volume>
<fpage>116</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1016/S1521-6616(03)00046-9</pub-id>
<pub-id pub-id-type="pmid">12763480</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fae</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Oshiro</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Toubert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Charron</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kalil</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guilherme</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease</article-title>
<source>J Autoimmun</source>
<year>2005</year>
<volume>24</volume>
<fpage>101</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2005.01.007</pub-id>
<pub-id pub-id-type="pmid">15829402</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fae</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kalil</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Toubert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guilherme</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern</article-title>
<source>Mol Immunol</source>
<year>2004</year>
<volume>40</volume>
<fpage>1129</fpage>
<lpage>1135</lpage>
<pub-id pub-id-type="doi">10.1016/j.molimm.2003.11.007</pub-id>
<pub-id pub-id-type="pmid">15036919</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilherme</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fae</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oshiro</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Kalil</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Molecular pathogenesis of rheumatic fever and rheumatic heart disease</article-title>
<source>Expert Rev Mol Med</source>
<year>2005</year>
<volume>7</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1017/S146239940501015X</pub-id>
<pub-id pub-id-type="pmid">16336741</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olive</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Dyer</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus</article-title>
<source>J Infect Dis</source>
<year>2006</year>
<volume>193</volume>
<fpage>1666</fpage>
<lpage>1676</lpage>
<pub-id pub-id-type="doi">10.1086/504266</pub-id>
<pub-id pub-id-type="pmid">16703510</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giovannoni</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>PANDAS: overview of the hypothesis</article-title>
<source>Adv Neurol</source>
<year>2006</year>
<volume>99</volume>
<fpage>159</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="pmid">16536362</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perlmutter</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Leitman</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Garvey</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Therapeutic plasma exchange and intravenous immunoglobulin for obsessive–compulsive disorder and tic disorders in childhood</article-title>
<source>Lancet</source>
<year>1999</year>
<volume>354</volume>
<fpage>1153</fpage>
<lpage>1158</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(98)12297-3</pub-id>
<pub-id pub-id-type="pmid">10513708</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Loiselle</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Minzer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Swedo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grus</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Anti-basal ganglia antibodies in PANDAS</article-title>
<source>Mov Disord</source>
<year>2004</year>
<volume>19</volume>
<fpage>406</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.1002/mds.20052</pub-id>
<pub-id pub-id-type="pmid">15077238</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Jablonka</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>M</given-names>
</name>
</person-group>
<source>Evolution in four dimensions</source>
<year>2005</year>
<edition>1</edition>
<publisher-loc>Boston</publisher-loc>
<publisher-name>MIT Press</publisher-name>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lederberg</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Infectious history</article-title>
<source>Science</source>
<year>2000</year>
<volume>288</volume>
<fpage>287</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1126/science.288.5464.287</pub-id>
<pub-id pub-id-type="pmid">10777411</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000241 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000241 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:7090595
   |texte=   Infections and Autoimmunity: A Panorama
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:18231878" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021